<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        110-276-13
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2013
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ROTARIX ORAL SUSPENSION VACCINE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HUMAN ROTAVIRUS, LIVE ATTENUATED VACCINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1000000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        200.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GlaxoSmithKline Biologicals " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GlaxoSmithKline Biologicals 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1182]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J07BH01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Rotarix is a viral vaccine, containing live, attenuated human rotavirus, that helps to protect your child, from the age of 6 weeks, against gastro-enteritis (diarrhoea and vomiting) caused by rotavirus infection.</p><p>&nbsp;</p><p><strong>How Rotarix works</strong></p><p>&nbsp;</p><p>Rotavirus infection is the most common cause of severe diarrhoea in infants and young children. Rotavirus is easily spread from hand-to-mouth due to contact with stools from an infected person. Most children with rotavirus diarrhoea recover on their own. However, some children become very ill with severe vomiting, diarrhoea and life-threatening loss of fluids that requires hospitalisation.</p><p>&nbsp;</p><p>When a person is given the vaccine, the immune system (the body&rsquo;s natural defences) will make antibodies against the most commonly occurring types of rotavirus. These antibodies protect against disease caused by these types of rotavirus.</p><p>&nbsp;</p><p>As with all vaccines, Rotarix may not completely protect all people who are vaccinated against the rotavirus infections it is intended to prevent.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Rotarix should not be given</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if your child has previously had any allergic reaction to rotavirus vaccines or any of the other ingredients of this vaccine (listed in section 6). Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if your child has previously had intussusception (a bowel obstruction in which one segment of bowel becomes enfolded within another segment).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if your child was born with a malformation of the gut that could lead to intussusception.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if your child has a rare inherited illness which affects their immune system called Severe Combined Immunodeficiency (SCID).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if your child has a severe infection with a high temperature. It might be necessary to postpone the vaccination until recovery. A minor infection such as a cold should not be a problem, but talk to your doctor first.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if your child has diarrhoea or is vomiting. It might be necessary to postpone the vaccination until recovery.</p><p><strong>&nbsp;</strong></p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor/health care professional before your child receives Rotarix if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; he/she has a close contact such as a household member who has a weakened immune system, e.g., a person with cancer or who is taking medicines that may weaken the immune system.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; he/she has any disorder of the gastrointestinal system.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; he/she has not been gaining weight and growing as expected.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; he/she has any disease or is taking any medicine which reduces his/her resistance to infection or if his/her mother has taken during pregnancy any medicine that may weaken the immune system.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking Immunosuppressive therapies including irradiation, antimetabolites, alkylating agents, cytotoxic drugs and corticosteroids (used in greater than physiologic doses), may reduce the immune response to vaccines.</p><p><strong>&nbsp;</strong></p><p>After your child has received Rotarix, contact a doctor/health care professional right away if your child experiences severe stomach pain, persistent vomiting, blood in stools, a swollen belly and/or high fever (see also section 4 &ldquo;Possible side effects&rdquo;).</p><p>&nbsp;</p><p>As always, please take care to wash your hands thoroughly after changing soiled nappies.</p><p>&nbsp;</p><p><strong>Other medicines and Rotarix</strong></p><p>Tell your doctor if your child is taking, has recently taken or might take any other medicines or has recently received any other vaccine.</p><p>&nbsp;</p><p>Rotarix may be given at the same time your child receives other normally recommended vaccines, such as diphtheria, tetanus, pertussis (whooping cough), <em>Haemophilus influenzae</em> type b, oral or inactivated polio, hepatitis B vaccines as well as pneumococcal and meningococcal serogroup C conjugate vaccines.</p><p><strong>&nbsp;</strong></p><p><strong>Rotarix with food and drink</strong></p><p>There are no restrictions on your child&rsquo;s consumption of food or liquids, either before or after vaccination.</p><p>&nbsp;</p><p><strong>Breast-feeding</strong></p><p>Based on evidence generated in clinical trials, breast-feeding does not reduce the protection against rotavirus gastro-enteritis afforded by Rotarix. Therefore, breast-feeding may be continued during the vaccination schedule.</p><p>&nbsp;</p><p><strong>Rotarix contains sucrose, glucose, phenylalanine and sodium</strong></p><p>If you have been told by your doctor that the child being vaccinated has an intolerance to some sugars, contact your doctor before your child receives this vaccine.</p><p>&nbsp;</p><p>This vaccine contains 0.15&nbsp;microgram phenylalanine in each dose. Phenylalanine may be harmful if your child has phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.</p><p>&nbsp;</p><p>This vaccine contains 32&nbsp;mg sodium (main component of cooking/table salt) in each dose.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The doctor or nurse will administer the recommended dose of Rotarix to your child. The vaccine (1.5 mL liquid) will be given <strong>orally</strong>. Under no circumstance should this vaccine be administered by injection.</p><p>&nbsp;</p><p>Your child will receive two doses of the vaccine. Each dose will be given on a separate occasion with an interval of at least 4 weeks between the two doses. The first dose may be given from the age of 6 weeks. The two doses of the vaccine must have been given by the age of 24 weeks, although they should preferably have been given before 16 weeks of age.</p><p>&nbsp;</p><p>Rotarix may be given according to the same vaccination course to infants who were born prematurely, provided that the pregnancy had lasted at least 27 weeks.</p><p>&nbsp;</p><p>In case your child spits out or regurgitates most of the vaccine dose, a single replacement dose may be given at the same vaccination visit.</p><p>&nbsp;</p><p>When Rotarix is given to your child for the first dose, it is recommended that your child also receives Rotarix (and not another rotavirus vaccine) for the second dose.</p><p>&nbsp;</p><p>It is important that you follow the instructions of your doctor or nurse regarding return visits. If you forget to go back to your doctor at the scheduled time, ask your doctor for advice.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this vaccine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>The following side effects may happen with this vaccine:</p><p>&nbsp;</p><p>&uml;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common (These may occur with up to 1 in 10 doses of the vaccine):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irritability</p><p>&nbsp;</p><p>&uml;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon (These may occur with up to 1 in 100 doses of the vaccine):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abdominal pain (see also below for signs of very rare side effects of intussusception)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flatulence</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the skin</p><p>&nbsp;</p><p>Side effects that have been reported during marketed use of Rotarix include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare: hives (urticaria)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare: intussusception (part of the intestine gets blocked or twisted). The signs may include severe stomach pain, persistent vomiting, blood in stools, a swollen belly and/or high fever. <strong>Contact a doctor/health care professional right away if your child experiences one of these symptoms</strong>.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood in stools</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In babies born very prematurely (at or before 28 weeks of gestation) longer gaps than normal between breaths may occur for 2-3 days after vaccination.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Children with a rare inherited illness called Severe Combined Immunodeficiency (SCID) may have an inflamed stomach or gut (gastroenteritis) and pass the vaccine virus in their stools. The signs of gastroenteritis may include feeling sick, being sick, stomach cramps or diarrhoea.</p><p><strong>&nbsp;</strong></p><p><strong>To report any side effect(s):</strong></p><p>&nbsp;</p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Reporting Hotline: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p><strong>-GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: Saudi.safety@gsk.com<u>&nbsp; </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Keep this vaccine out of the sight and reach of children.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this vaccine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Store in a refrigerator (2 &deg;C &ndash; 8 &deg;C).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Do not freeze.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Store in the original package in order to protect from light.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; The vaccine should be used immediately after opening.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines your child no longer uses. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Rotarix contains</strong></p><p><strong><u>&nbsp;</u></strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substances are:</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Human rotavirus RIX4414 strain (live, attenuated)* &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not less than 10<sup>6.0</sup> CCID<sub>50</sub></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Produced on Vero cells</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients in Rotarix are: sucrose, Di-sodium Adipate, Dulbecco&rsquo;s Modified Eagle Medium (DMEM) (containing phenylalanine, sodium, glucose, and other substances), sterile water, (see also section 2, &ldquo;Rotarix contains sucrose, glucose, phenylalanine and sodium&rdquo;)</p><p>The following information is intended for healthcare professionals only:</p><p>&nbsp;</p><p>The vaccine is presented as a clear, colourless liquid, free of visible particles, for <strong>oral</strong> administration.</p><p>&nbsp;</p><p>The vaccine is ready to use (no reconstitution or dilution is required).</p><p>The vaccine is to be administered <strong>orally </strong>without mixing with any other vaccines or solutions.</p><p>&nbsp;</p><p>The vaccine should be inspected visually for any foreign particulate matter and/or abnormal physical appearance. In the event of either being observed, discard the vaccine.</p><p>&nbsp;</p><p>Any unused vaccine or waste material should be disposed of in accordance with local requirements.</p><p><img src="data:image/png;base64,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" alt="" width="400" height="405" vspace="0" hspace="0" border="0" style="width:400px;height:405px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                	Oral suspension in pre-filled oral applicator.

Rotarix is supplied as clear and colourless liquid in a single dose pre-filled oral applicator (1.5 mL).
Rotarix is available in a pack of 1, 5, 10 or 25.
Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong><u>Marketing Authorisation Holder</u></strong></p><p><strong><u>&nbsp;</u></strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia</p><p>*member of the GlaxoSmithKline group of companies GlaxoSmithKline UK Limited</p><p>&nbsp;</p><p><strong><u>Manufacturer</u></strong></p><p>&nbsp;</p><p>GlaxoSmithKline Biologicals s.a.</p><p>Rue de l&rsquo;Institut 89</p><p>B-1330 Rixensart</p><p>Belgium</p><p><strong>&nbsp;</strong></p><p>Trade marks are owned by or licensed to the GSK group of companies.</p><p>&copy; 2024 GSK group of companies or its licensor.</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version number: UK Issue13 draft1 
Date of issue: 15 March 2024

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">روتاريكس هو لقاح فيروسي، يحتوي على فيروس روتا البشري الحي المضعف، يساعد على حماية طفلك، من سن 6 أسابيع، ضد التهاب المعدة والأمعاء (الإسهال والقيء) الناجم عن العدوى الفيروسة العجلية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ألية عمل لقاح روتاريكس</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">تعد العدوى الفيروسة العجلية السبب الأكثر شيوعًا للإصابة بالإسهال الشديد عند الرضع والأطفال الصغار. وينتشر فيروس الروتا بسهولة من اليد إلى الفم بسبب ملامسة البراز من شخص مصاب. يتعافى معظم الأطفال المصابين بالإسهال الناجم عن فيروس الروتا من تلقاء أنفسهم. ومع ذلك، يصاب بعض الأطفال بمرض شديد مع القيء الشديد والإسهال وفقدان السوائل الذي يهدد الحياة مما يتطلب العلاج في المستشفى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">عندما يتلقى الشخص اللقاح، فإن الجهاز المناعي (دفاعات الجسم الطبيعية) يُكون أجسامًا مضادة ضد أكثر أنواع الفيروسات العجلية شيوعًا. تحمي هذه الأجسام المضادة من الأمراض التي تسببها هذه الأنواع من الفيروسات العجلية.</p><p dir="RTL">كما هو الحال مع جميع اللقاحات، قد لا يحمي لقاح روتاريكس تمامًا جميع الأشخاص الذين يتم تطعيمهم ضد العدوى الفيروسة العجلية فهو يستخدم للوقاية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع تلقي لقاح روتاريكس</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان طفلك قد عانى سابقًا من أي رد فعل تحسسي تجاه لقاحات الفيروسة العجلية أو أي من المكونات الأخرى لهذا اللقاح (المدرجة في القسم 6). قد تشمل علامات رد الفعل التحسسي طفح جلدي وحكة وضيق في التنفس وتورم في الوجه أو اللسان.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان طفلك قد عانى سابقًا من انغلاف معوي (انسداد معوي ينزلق فيه جزء من الأمعاء داخل جزء آخر).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا ولد طفلك بتشوه في القناة الهضمية يمكن أن يؤدي إلى انغلاف معوي.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان طفلك يعاني من مرض وراثي نادر يؤثر على جهاز المناعة يسمى العوز المناعي المشترك الشديد (SCID).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان طفلك يعاني من عدوى شديدة مع ارتفاع في درجة الحرارة. قد يكون من الضروري تأجيل التطعيم حتى الشفاء. لا تُعد العدوى البسيطة مثل البرد مشكلة، لكن يرجى التحدث مع الطبيب المعالج أولاً.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان طفلك يعاني من الإسهال أو قيء. قد يكون من الضروري تأجيل التطعيم حتى الشفاء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">يرجى التحدث إلى الطبيب المعالج أو أخصائي الرعاية الصحية قبل أن يتلقى طفلك لقاح روتاريكس إذا:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديه أو لديها اتصال وثيق مثل أحد أفراد الأسرة الذي يعاني من ضعف في جهاز المناعة، على سبيل المثال، شخص مصاب بالسرطان أو يتناول أدوية قد تضعف جهاز المناعة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديه أو لديها أي اضطراب في الجهاز الهضمي.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لم يكتسب المريض أو المريضة وزنًا، ولم ينمو كما هو متوقع.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان يعاني من أي مرض أو يتناول أي دواء يقلل من مقاومته للعدوى أو إذا كانت والدته قد تناولت أثناء الحمل أي دواء قد يضعف جهاز المناعة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تقلل العلاجات المثبطة للمناعة التي تشمل العلاج الإشعاعي ومضادات الأيض والعوامل المؤلكلة والأدوية السامة للخلايا والكورتيكوستيرويدات (المستخدمة بجرعات أكبر من الجرعات الفسيولوجية) الاستجابة المناعية للقاحات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">بعد أن يتلقى طفلك لقاح روتاريكس، يرجى الاتصال بالطبيب المعالج أو أخصائي الرعاية الصحية على الفور؛ إذا كان طفلك يعاني من ألم شديد في المعدة، أو قيء مستمر، أو دم في البراز، أو انتفاخ في البطن، أو ارتفاع في درجة الحرارة (انظر أيضًا القسم 4 &quot;الآثار الجانبية المحتملة&quot;).</p><p dir="RTL">&nbsp;</p><p dir="RTL">كما هو الحال دائمًا؛ يرجى الحرص على غسل يديك جيدًا بعد تغيير الحفاضات المتسخة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخل بين الأدوية الأخرى ولقاح الروتاريكس</strong></p><p dir="RTL"><br />أخبر الطبيب المعالج إذا كان طفلك يتناول أو تناول مؤخرًا أو يمكن أن يتناول أي أدوية أخرى أو تلقى مؤخرًا أي لقاح آخر.</p><p dir="RTL">يمكن إعطاء لقاح روتاريكس في نفس الوقت الذي يتلقى فيه طفلك لقاحات أخرى موصى بها عادة، مثل الدفتيريا، والكزاز، والشاهوق (السعال الديكي)، والمستدمية النزلية من النوع ب، وشلل الأطفال الفموي أو المعطل، ولقاحات التهاب الكبد بي، وكذلك لقاحات المكورات الرئوية والمكورات السحائية المقترنة من المجموعة المصلية سي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لقاح روتاريكس مع الطعام والشراب</strong></p><p dir="RTL">لا توجد قيود على استهلاك طفلك للطعام أو السوائل، سواء قبل التطعيم أو بعده.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الرضاعة الطبيعية </strong></p><p dir="RTL">استنادًا إلى الأدلة التي تم الحصول عليها في التجارب السريرية، تبين أن الرضاعة الطبيعية لا تقلل من الحماية ضد التهاب المعدة والأمعاء الناتج عن الفيروسة العجلية التي يوفرها لقاح روتاريكس. لذلك، قد تستمر الرضاعة الطبيعية خلال جدول التطعيم.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>يحتوي لقاح روتاريكس على السكروز والجلوكوز والفينيل ألانين والصوديوم</strong></p><p dir="RTL">إذا أخبرك طبيبك المعالج أن الطفل الذي يتم تطعيمه يعاني من عدم تحمل بعض السكريات، فاتصل بطبيبك المعالج قبل أن يتلقى طفلك هذا اللقاح.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي هذا اللقاح على 0.15 ميكروجرام من فينيل ألانين في كل جرعة. قد يكون الفينيل ألانين ضارًا إذا كان طفلك يعاني من بيلة الفينيل كيتون (PKU)، وهو اضطراب وراثي نادر يتراكم فيه الفينيل ألانين، لأن الجسم لا يستطيع التخلص منه بشكل صحيح.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي هذا اللقاح على 32 مجم من الصوديوم (المكون الرئيسي للطبخ / ملح الطعام) في كل جرعة.</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيقوم الطبيب المعالج أو الممرضة بإعطاء الجرعة الموصي بها من لقاح روتاريكس لطفلك. اللقاح (1.5 مل سائل) يعطى عن طريق الفم. لا ينبغي تحت أي ظرف من الظروف إعطاء هذا اللقاح عن طريق الحقن.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيحصل طفلك على جرعتين من اللقاح. سيتم إعطاء كل جرعة في وقت منفصل بفاصل 4 أسابيع على الأقل بين الجرعتين. يمكن إعطاء الجرعة الأولى من عمر 6 أسابيع. يجب إعطاء جرعتين من اللقاح قبل سن 24 أسبوعًا، على الرغم من أنه من الأفضل إعطاؤهما قبل سن 16 أسبوعًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن إعطاء لقاح روتاريكس وفقًا لنفس برنامج التطعيم للرضع الذين ولدوا قبل الأوان، بشرط أن يكون الحمل قد استمر 27 أسبوعًا على الأقل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالة قيام طفلك ببصق أو تقيأ معظم جرعة اللقاح، يمكن إعطاء جرعة بديلة واحدة في نفس زيارة التطعيم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">عندما يُعطى لقاح روتاريكس لطفلك بالجرعة الأولى، يوصى بأن يتلقى طفلك أيضًا لقاح روتاريكس (وليس لقاح فيروس روتا آخر) للجرعة الثانية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">من المهم أن تتبع تعليمات طبيبك المعالج أو ممرضتك فيما يتعلق بزيارات العودة.</p><p dir="RTL">إذا نسيت العودة إلى طبيبك المعالج في الوقت المحدد، فيرجى طلب النصيحة من طبيبك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL">مثل جميع الأدوية، يمكن أن يسبب هذا اللقاح آثارًا جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن تحدث الآثار الجانبية التالية مع هذا اللقاح:</p><p dir="RTL">&nbsp;</p><p dir="RTL">الشائعة (قد تحدث مع ما يصل إلى جرعة واحدة من كل 10 جرعات من اللقاح):</p><p dir="RTL">&bull; إسهال.</p><p dir="RTL">&bull; التهيج.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">غير الشائعة (قد تحدث مع جرعة واحدة من كل 100 جرعة من اللقاح):</p><p dir="RTL">&bull; ألم في البطن (انظر أيضًا أدناه للتعرف على علامات الآثار الجانبية النادرة جدًا للانغلاف المعوي).</p><p dir="RTL">&bull; انتفاخ.</p><p dir="RTL">&bull; التهاب الجلد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تشمل الآثار الجانبية التي تم الإبلاغ عنها أثناء الاستخدام التسويقي للقاح روتاريكس ما يلي:</p><p dir="RTL">&bull; نادر جدًا: خلايا النحل (شرى)</p><p dir="RTL">&bull; نادر جدا: الانغلاف المعوي (يحدث انسداد أو التواء في جزء من الأمعاء). قد تشمل العلامات آلام شديدة في المعدة، وقيء مستمر، ودم في البراز، وانتفاخ في البطن منتفخ، وارتفاع في درجة الحرارة. اتصل بالطبيب المعالج أوأخصائي الرعاية الصحية على الفور إذا كان طفلك يعاني من أحد هذه الأعراض.</p><p dir="RTL">&bull; دم في البراز.</p><p dir="RTL">&bull; عند الأطفال المولودين قبل الأوان (عند أو قبل 28 أسبوعًا من الحمل) قد تحدث فجوات أطول من المعتاد بين الأنفاس لمدة 2-3 أيام بعد التطعيم.</p><p dir="RTL">&bull; الأطفال الذين يعانون من مرض وراثي نادر يسمى عوز المناعة المشترك الشديد (SCID) قد يكون لديهم التهاب في المعدة أو الأمعاء (التهاب المعدة والأمعاء) ويمررون فيروس اللقاح في برازهم. يمكن أن تشمل علامات التهاب المعدة والأمعاء الشعور بالغثيان أو التعب أو تقلصات المعدة أو الإسهال.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا أصيب طفلك بأي من الآثار الجانبية، تحدث إلى طبيبك المعالج أو الصيدلي. يتضمن ذلك أي آثار جانبية محتملة غير مذكورة في هذه النشرة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن أية آثار جانبية</strong><strong>:</strong></p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- </strong><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong><strong>(</strong><strong>NPC</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاتصال بالرقم الموحد: 19999</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL">- <strong>جلاكسو</strong><strong> </strong><strong>سميث</strong><strong> </strong><strong>كلاين</strong><strong> </strong><strong>&ndash; المقر الرئيسي، جدة</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: &nbsp;6536666 (12) 966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوّال:&nbsp; 9882-904-56&nbsp; 966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد اًللكتروني: &nbsp;saudi.safety@gsk.com</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع اًلإلكتروني: https://gskpro.com/en-sa/</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب. 55850، جدة 21544، المملكة العربية السعودية</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﯾﺠﺐ ﺣﻔﻆ اﻟﺪواء ﺑﻌﯿﺪًا ﻋﻦ ﻣﺮأى وﻣﺘﻨﺎول اﻷطﻔﺎل. ﯾﺤﻔﻆ ﻓﻲ اﻟﺜﻼﺟﺔ (ﺑﯿﻦ درﺟﺘﯿﻦ ﻣﺌﻮﯾﺘﯿﻦ و٨ درﺟﺎت ﻣﺌﻮﯾﺔ).</p><ul><li dir="RTL">لا تستخدم الدواء بعد مرور فترة الصلاحية الموضحة على الملصق والعبوة الورقية بعد كلمة: EXP . تاريخ انتهاء الصلاحية يشير لأخر يوم في الشهر المذكور.</li></ul><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﯾﺠﺐ ﻋﺪم ﺗﺠﻤﯿﺪه.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﯾﺤﻔﻆ ﻓﻲ اﻟﻌﺒﻮة اﻷﺻﻠﯿﺔ ﻟﺤﻤﺎﯾﺘﮫ ﻣﻦ اﻟﻀﻮء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻻ ﺗﺴﺘﺨﺪم اﻟﺪواء ﺑﻌﺪ ﺗﺎرﯾﺦ اﻧﺘﮭﺎء اﻟﺼﻼﺣﯿﺔ اﻟﻤﺪوﱠ ن ﻋﻠﻰ اﻟﻌﺒﻮة. ﯾﺸﯿﺮ ﺗﺎرﯾﺦ اﻧﺘﮭﺎء اﻟﺼﻼﺣﯿﺔ إﻟﻰ اﻟﯿﻮم اﻷﺧﯿﺮ ﻣﻦ اﻟﺸﮭﺮ اﻟﻤﺬﻛﻮر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻻ ﺗﺘﺨﻠﺺ ﻣﻦ أي أدوﯾﺔ ﺑﺈﻟﻘﺎﺋﮭﺎ ﻓﻲ ﻣﯿﺎه اﻟﺼﺮف اﻟﺼﺤﻲ أو اﻟﻨﻔﺎﯾﺎت اﻟﻤﻨﺰﻟﯿﺔ. اﺳﺘﺸﺮ اﻟﺼﯿﺪﻟﻲ ﻋﻦ ﻛﯿﻔﯿﺔ اﻟﺘﺨﻠﺺ ﻣﻦ اﻷدوﯾﺔ اﻟﺘﻲ ﻟﻢ ﺗﻌﺪ ﺗﺴﺘﻌﻤﻠﮭﺎ. ﻓﮭﺬه اﻹﺟﺮاءات ﻣﻦ ﺷﺄﻧﮭﺎ أن ﺗﺤﺎﻓﻆ ﻋﻠﻰ اﻟﺒﯿﺌﺔ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ﻣﻛوّﻧﺎت </strong><strong>روتاريكس</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">مكونات لقاح لروتاريكس</p><p dir="RTL">&nbsp;</p><p dir="RTL">- المواد الفعالة هي:</p><p dir="RTL">&nbsp;</p><p dir="RTL">سلالة فيروس الروتا البشري RIX4414 (حية، موهنة) * &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;لا تقل عن 10^6.0 متوسط الجرعة المعدية من زراعة الخلايا</p><p dir="RTL">&nbsp;</p><p dir="RTL">* تم إنتاجه على خلايا فيرو.</p><p dir="RTL">&nbsp;</p><p dir="RTL">- المكونات الأخرى الموجود في لقاح روتاريكس هي: السكروز، ثنائي الصوديوم أديبات، دولبيكو موديفايد إيجل ميديم (DMEM) (يحتوي على فينيل ألانين، وصوديوم، وجلوكوز، ومواد أخرى)، وماء معقم، (انظر أيضًا القسم 2، &quot;يحتوي روتاريكس على السكروز والجلوكوز والفينيل ألانين والصوديوم &quot;)</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شكل لقاح روتاريكس، ومحتويات العبوة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلق</strong> فموي في أداة طبية <strong>فموية</strong> مملوء مسبقًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتم توفير لقاح روتاريكس كسائل صافٍ وعديم اللون في أداة طبية فموية مملوء مسبقًا لإعطاء جرعة واحدة. (1.5 مل).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتوفر لقاح روتاريكس في عبوات بحجم 1 أو 5 أو 10 أو 25.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p><p dir="RTL">المعلومات التالية مقدمة للمتخصصين في الرعاية الصحية فقط:</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتوفر اللقاح على شكل سائل صافٍ وعديم اللون وخالٍ من الجزيئات المرئية، للإعطاء عن طريق الفم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">اللقاح جاهز للاستخدام (لا يلزم إعادة التركيب أو التخفيف).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يُعطى اللقاح عن طريق الفم، بدون الاختلاط بأي لقاحات أو محاليل أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﯾﻨﺒﻐﻲ ﻓﺤﺺ اﻟﻠﻘﺎح ﺑﺒﺼﺮك ﻟﻠﺘﺄﻛﺪ ﻣﻦ ﻋﺪم وﺟﻮد أي ﺟﺴﯿﻤﺎت و/أو ﻣﻼﺣﻈﺔ ﺗﻐﯿﺮ ﻓﻲ اﻟﺠﺎﻧﺐ اﻟﻤﺎدي.</p><p dir="RTL">ﯾﻨﺒﻐﻲ اﻟﺘﺨﻠّﺺ ﻣﻦ أي ﻣﻨﺘﺞ ﻏﯿﺮ ﻣﺴﺘﻌﻤﻞ أو ﻣﺨﻠﻔﺎت دواﺋﯿﺔ وﻓﻖ اﻟﻤﺘﻄﻠﺒﺎت اﻟﻤﺤﻠﯿﺔ. ﻓﻲ ﺣﺎﻟﺔ وﺟﻮد &nbsp;أي من الامرين، ﻻ ﺗﻘﻢ ﺑﺈﻋﻄﺎء اﻟﻠﻘﺎح.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>تعليمات تحضير اللقاح:</u></p><p dir="RTL">&nbsp;</p><p dir="RTL"><!--[if gte vml 1]><o:wrapblock><v:rect id="Rectangle_x0020_10"
  o:spid="_x0000_s1029" style='position:absolute;left:0;text-align:left;
  margin-left:338.25pt;margin-top:1.5pt;width:108pt;height:36pt;z-index:251664384;
  visibility:visible;mso-wrap-style:square;mso-width-percent:0;
  mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
  mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
  mso-position-horizontal-relative:text;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;mso-width-percent:0;mso-width-relative:margin;
  v-text-anchor:middle' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF
dyTewfKKEqcMCKEmHfgZgaE8wMW+SSwc27JvS/v23KTJgkoXFsu+P+c7Ol5vDoMTe0zZBl/LVVlJ
gV4HY31Xy4/tS3EvRSbwBlzwWMsjZrlprq/W22PELHjb51r2RPFBqax7HCCXIaLnThvSAMTP1KkI
+gs6VLdVdad08ISeCho1ZLN+whZ2jsTzgcsnJwldluLxNDiyagkxOquB2Knae/OLUsyEkjenmdzb
mG/YhlRnCWPnb8C898bRJGtQvEOiVxjYhtLOxs8AySiT4JuDystlVV4WPeM6tK3VaILeDZxIOSsu
ti/jidNGNZ3/J08yC1dNv9v8AAAA//8DAFBLAwQUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAF9y
ZWxzLy5yZWxzhI/NCsIwEITvgu8Q9m7TehCRpr2I4FX0AdZk2wbbJGTj39ubi6AgeJtl2G9m6vYx
jeJGka13CqqiBEFOe2Ndr+B03C3WIDihMzh6RwqexNA281l9oBFTfuLBBhaZ4ljBkFLYSMl6oAm5
8IFcdjofJ0z5jL0MqC/Yk1yW5UrGTwY0X0yxNwri3lQgjs+Qk/+zfddZTVuvrxO59CNCmoj3vCwj
MfaUFOjRhrPHaN4Wv0VV5OYgm1p+LW1eAAAA//8DAFBLAwQUAAYACAAAACEA3xgFvcEDAAD7CAAA
HwAAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWzcVk1v2zYYvg/YfyB4Ty05idMYVQrH
q4MBQRvELXpmKMoWSpEaSTtOby3Wodu/KHpodxqwS4H9Evvf7CEpya5XrMC202BA1vvJ5/2kHjxc
VZIshbGlVhlN7yWUCMV1XqpZRp89nRzcp8Q6pnImtRIZvROWPjz79psHbDgzrJ6XnMCDskOW0blz
9bDXs3wuKmbv6VooyAptKuZAmlkvN+wWnivZ6yfJoFexUtGzravvmGNkYcp/4Epq/kLkY6aWzMKl
5MNdToNR8n/vmQ3V8sLU0/rKeOT88fLKkDLPKDKnWIUU0V4jaNRA9vasZlsHq8JUXl8XBVll9Lif
JunJMSV3GR2c9k/TfhL9iZUjHArp4Uk6SHAYh8bR8QkS2Rw4f/IVF3z+6O+dAGaEg5cdiLb2ANXy
rzGnXdDXgqNLZlIQ8NoEeIM2+tbYNon7j+LuILNhbay7ELoi/iWjBohCc7HlpXURRqvi45HKP62W
ZT4ppQyE71wxloYsmczozSz1oeCIHS1Q3tIzm0jcahoS5FbnOr/zfm7wj64wGjCQIVvzSQlMl8y6
K2YwKWBi5twTPAqpbzPKZVlTMtfm5T7P66FrIaHkFhOXUfvDghlBifxe2YyepkdHcOcCEfqBErMr
udmVqEU11ggtDajCK4yNky23MLp6rk0+8qdCxBTH2QDoTEuMHWiIMNhcjEbhneuqZu5STWuMWBrS
7nP9dPWcmbopiEMLP9bTOavFl+oSdX36lB4tnC7Kpmgxm14grZu6OylCf4WcowSkYuYygMDLdQQt
Z1hmATJCawFJjy6UueZX3MUap8lJEicoFHarcS6KVtfZqBsaOxSeb6Wjwu3r3e8covJBDqOmWcLS
MEAtMS0ZZebg0QVq8RIgU5h5V6Io0LqxZ0Ex4u5qUTCO1TJmsrwxJSU1U9qCkfSTSXKMp/8dJYf+
CWnp+HzCqlJiRxyCwefMWBEqGnLH7Y7TkSmZ/MzleTKAs+g0OP6qSwSIoDx6d7Z5vXlD1h/XH9a/
rz9sflz/SsLfH+tPYL0LxOYtWK83P5PNm81PUfx+/RvEje6n9cfNLw2xeQWlt570Q4dk+7NCnlTu
p+m6S6ZQB8+m/49kii62EC963cfeLZiFFdPar9y4ntoNZP1w+NRIdS0K3Eq4L/qhp8KdvN1sjHOh
3KDZbkHbmxXYg51hnOI9Q+naldjohkKEhu0MYxfvGX5+YmxxWIRTtXKdcVUqbb4EOX/RnRz14w6O
ESM5/pLq7V37QaX5TPHfFrv02Z8AAAD//wMAUEsDBBQABgAIAAAAIQCSfYfgHQcAAEkgAAAaAAAA
Y2xpcGJvYXJkL3RoZW1lL3RoZW1lMS54bWzsWUtvGzcQvhfof1jsvbFkvWIjcmDJctzEL0RKihwp
idplzF0uSMqObkVy6qVAgbTooQF666EoGqABGvTSH2PAQZv+iA65L1Ki4gdcIChsAcbu7DfD4czs
zOzwzt1nEfWOMReExW2/eqviezgesTGJg7b/aLD92W3fExLFY0RZjNv+DAv/7sann9xB6yNKkiFD
fDwIcYQ9EBSLddT2QymT9ZUVMQIyErdYgmN4NmE8QhJuebAy5ugEFojoymql0lyJEIn9DZAolaAe
hX+xFIoworyvxGAvRhGsfjCZkBHW2PFRVSHETHQp944Rbfsgc8xOBviZ9D2KhIQHbb+i//yVjTsr
aD1jonIJr8G3rf8yvoxhfLSq1+TBsFi0Xm/Um5uFfA2gchHXa/WavWYhTwPQaAQ7TXWxZbZWu/UM
a4DSS4fsrdZWrWrhDfm1BZ03G+pn4TUolV9fwG9vd8GKFl6DUnxjAd/orHW2bPkalOKbC/hWZXOr
3rLka1BISXy0gK40mrVuvtsCMmF0xwlfa9S3W6uZ8BIF0VBEl1piwmK5LNYi9JTxbQAoIEWSxJ6c
JXiCRhCTXUTJkBNvlwQhBF6CYiaAXFmtbFdq8F/96vpKexStY2RwK71AE7FAUvp4YsRJItv+fZDq
G5Czt29Pn785ff776YsXp89/zdbWoiy+HRQHJt/7n77559WX3t+//fj+5bfp0vN4YeLf/fLVuz/+
/JB42HFpirPvXr978/rs+6//+vmlQ/omR0MTPiARFt4+PvEesgg26NAfD/nlOAYhIibHZhwIFCO1
ikN+T4YWen+GKHLgOti242MOqcYFvDd9aincD/lUEofEB2FkAfcYox3GnVZ4oNYyzDyYxoF7cT41
cQ8ROnat3UWx5eXeNIEcS1wiuyG21DykKJYowDGWnnrGjjB27O4JIZZd98iIM8Em0ntCvA4iTpMM
yNCKppJph0Tgl5lLQfC3ZZu9x16HUdeut/CxjYR3A1GH8gNMLTPeQ1OJIpfIAYqoafBdJEOXkv0Z
H5m4npDg6QBT5vXGWAgXzwGH/RpOfwBpxu32PTqLbCSX5MglcxcxZiK32FE3RFHiwvZJHJrYz8UR
hCjyDpl0wfeY/Yaoe/ADipe6+zHBlrvPzwaPIMOaKpUBop5MucOX9zCz4rc/oxOEXalmk0dWit3k
xBkdnWlghfYuxhSdoDHG3qPPHRp0WGLZvFT6fghZZQe7Aus+smNV3cdYYE83N4t5cpcIK2T7OGBL
9NmbzSWeGYojxJdJ3gevmzbvQamLXAFwQEdHJnCfQL8H8eI0yoEAGUZwL5V6GCKrgKl74Y7XGbf8
d5F3DN7Lp5YaF3gvgQdfmgcSu8nzQdsMELUWKANmgKDLcKVbYLHcX7Ko4qrZpk6+if3Slm6A7shq
eiISn9sBzfU+jf+u94EO4+yHV46X7Xr6HbdgK1ldstNZlkx25vqbZbj5rqbL+Jh8/E3NFprGhxjq
yGLGuulpbnoa/3/f0yx7n286mWX9xk0n40OHcdPJZMOV6+lkyuYF+ho18EgHPXrsEy2d+kwIpX05
o3hX6MGPgO+Z8TYQFZ+ebuJiCpiEcKnKHCxg4QKONI/HmfyCyLAfogSmQ1VfCQlEJjoQXsIEDI00
2Slb4ek02mPjdNhZrarBZlpZBZIlvdIo6DCokim62SoHeIV4rW2gB625Aor3MkoYi9lK1BxKtHKi
MpIe64LRHEronV2LFmsOLW4r8bmrFrQA1QqvwAe3B5/pbb9RBxZggnkcNOdj5afU1bl3tTOv09PL
jGlFADTYeQSUnl5Tui7dntpdGmoX8LSlhBFuthLaMrrBEyF8BmfRqagXUeOyvl4rXWqpp0yh14PQ
KtVo3f6QFlf1NfDN5wYam5mCxt5J22/WGhAyI5S0/QkMjeEySiB2hPrmQjSA45aR5OkLf5XMknAh
t5AIU4PrpJNmg4hIzD1Koravtl+4gcY6h2jdqquQED5a5dYgrXxsyoHTbSfjyQSPpOl2g6Isnd5C
hk9zhfOpZr86WHGyKbi7H45PvCGd8ocIQqzRqioDjomAs4Nqas0xgcOwIpGV8TdXmLK0a55G6RhK
6YgmIcoqipnMU7hO5YU6+q6wgXGX7RkMapgkK4TDQBVY06hWNS2qRqrD0qp7PpOynJE0y5ppZRVV
Nd1ZzFohLwNztrxakTe0yk0MOc2s8Gnqnk+5a3mum+sTiioBBi/s56i6FygIhmrlYpZqSuPFNKxy
dka1a0e+wXNUu0iRMLJ+Mxc7Z7eiRjiXA+KVKj/wzUctkCZ5X6kt7TrY3kOJNwyqbR8Ol2E4+Ayu
4HjaB9qqoq0qGlzBmTOUi/SguO1nFzkFnqeUAlPLKbUcU88p9ZzSyCmNnNLMKU3f0yeqcIqvDlN9
Lz8whRqWHbBmvYV9+r/xLwAAAP//AwBQSwMEFAAGAAgAAAAhAJxmRkG7AAAAJAEAACoAAABjbGlw
Ym9hcmQvZHJhd2luZ3MvX3JlbHMvZHJhd2luZzEueG1sLnJlbHOEj80KwjAQhO+C7xD2btJ6EJEm
vYjQq9QHCMk2LTY/JFHs2xvoRUHwsjCz7DezTfuyM3liTJN3HGpaAUGnvJ6c4XDrL7sjkJSl03L2
DjksmKAV201zxVnmcpTGKSRSKC5xGHMOJ8aSGtHKRH1AVzaDj1bmIqNhQaq7NMj2VXVg8ZMB4otJ
Os0hdroG0i+hJP9n+2GYFJ69elh0+UcEy6UXFqCMBjMHSldnnTUtXYGJhn39Jt4AAAD//wMAUEsB
Ai0AFAAGAAgAAAAhALvlSJQFAQAAHgIAABMAAAAAAAAAAAAAAAAAAAAAAFtDb250ZW50X1R5cGVz
XS54bWxQSwECLQAUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAAAAAAAAAAAAAAA2AQAAX3JlbHMv
LnJlbHNQSwECLQAUAAYACAAAACEA3xgFvcEDAAD7CAAAHwAAAAAAAAAAAAAAAAAgAgAAY2xpcGJv
YXJkL2RyYXdpbmdzL2RyYXdpbmcxLnhtbFBLAQItABQABgAIAAAAIQCSfYfgHQcAAEkgAAAaAAAA
AAAAAAAAAAAAAB4GAABjbGlwYm9hcmQvdGhlbWUvdGhlbWUxLnhtbFBLAQItABQABgAIAAAAIQCc
ZkZBuwAAACQBAAAqAAAAAAAAAAAAAAAAAHMNAABjbGlwYm9hcmQvZHJhd2luZ3MvX3JlbHMvZHJh
d2luZzEueG1sLnJlbHNQSwUGAAAAAAUABQBnAQAAdg4AAAAA
" fillcolor="white [3201]" strokecolor="white [3212]" strokeweight="1pt">
  <v:textbox>
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal align=center dir=RTL style='text-align:center'><span
     lang=AR-EG style='font-family:"Arial",sans-serif;mso-ascii-font-family:
     Calibri;mso-ascii-theme-font:minor-latin;mso-hansi-font-family:Calibri;
     mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi;
     mso-ansi-language:EN-GB;mso-bidi-language:AR-EG'>قم بازالة الغطاء الواقى
     من <a name="_Hlk115270551">الأداة الطبية الفموية</a><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_16" o:spid="_x0000_s1027" style='position:absolute;
  left:0;text-align:left;margin-left:60.75pt;margin-top:3.75pt;width:113.25pt;
  height:35.25pt;z-index:251666432;visibility:visible;mso-wrap-style:square;
  mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
  mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
  mso-position-horizontal-relative:text;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;v-text-anchor:middle' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" fillcolor="white [3201]" strokecolor="white [3212]" strokeweight="1pt">
  <v:textbox>
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal align=center dir=RTL style='text-align:center'><b><span
     lang=AR-EG style='font-family:"Arial",sans-serif;mso-ascii-font-family:
     Calibri;mso-ascii-theme-font:minor-latin;mso-hansi-font-family:Calibri;
     mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi;
     mso-ansi-language:EN-GB;mso-bidi-language:AR-EG'>يجب ان لأ يُحقن<o:p></o:p></span></b></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_14" o:spid="_x0000_s1028" style='position:absolute;
  left:0;text-align:left;margin-left:197.25pt;margin-top:2.25pt;width:112.5pt;
  height:132.75pt;z-index:251665408;visibility:visible;mso-wrap-style:square;
  mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
  mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
  mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
  mso-position-vertical:absolute;mso-position-vertical-relative:text;
  mso-height-percent:0;mso-height-relative:margin;v-text-anchor:middle'
  o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" fillcolor="white [3201]" strokecolor="white [3212]" strokeweight="1pt">
  <v:textbox>
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal align=center dir=RTL style='text-align:center'><span
     lang=AR-EG style='font-family:"Arial",sans-serif;mso-ascii-font-family:
     Calibri;mso-ascii-theme-font:minor-latin;mso-hansi-font-family:Calibri;
     mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi;
     mso-bidi-language:AR-EG'>يُعطى اللقاح عن <b>طريق الفم</b> <b>فقط</b></span><span
     lang=AR-SA style='font-family:"Arial",sans-serif;mso-ascii-font-family:
     Calibri;mso-ascii-theme-font:minor-latin;mso-hansi-font-family:Calibri;
     mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi'>.و يجب ان
     يكون طفلك فى وضع مائلا للوراء (مستلقيا ). ُيعطى </span><span lang=AR-EG
     style='font-family:"Arial",sans-serif;mso-ascii-font-family:Calibri;
     mso-ascii-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:
     minor-latin;mso-bidi-theme-font:minor-bidi;mso-bidi-language:AR-EG'>اللقاح
     كاملا الموجود فى الأداة الطبية الفموية عن <b>طريق</b> <b>الفم </b>(فى فم
     الطفل، تجاه الخد من الداخل</span><span lang=AR-SA style='font-family:"Arial",sans-serif;
     mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-hansi-font-family:
     Calibri;mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi'>)</span><span
     dir=LTR style='mso-bidi-language:AR-EG'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p>&nbsp;</p><p dir="RTL"><img alt="" width="400" height="225" src="data:image/png;base64,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" /></p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><img alt="" width="737" height="380" src="data:image/png;base64,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" /></p><p dir="RTL">&nbsp;</p><p>&nbsp;</p><p dir="RTL"><!--[if gte vml 1]><v:roundrect id="Rectangle_x003a__x0020_Rounded_x0020_Corners_x0020_8"
 o:spid="_x0000_s1026" style='position:absolute;left:0;text-align:left;
 margin-left:86.05pt;margin-top:5.35pt;width:456pt;height:178.95pt;z-index:251662336;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:page;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:middle' arcsize="10923f" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" fillcolor="window" strokecolor="windowText" strokeweight="2.25pt">
 <v:stroke joinstyle="miter"/>
 <v:path arrowok="t"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal dir=RTL style='margin-right:20.85pt;mso-add-space:auto;
    mso-layout-grid-align:none'><b><span lang=AR-SA style='font-size:12.0pt;
    line-height:107%;font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi'>ھﺬا اﻟﻤﻨﺘﺞ
    دواء</span></b><b><span dir=LTR style='font-size:12.0pt;line-height:107%;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-hansi-theme-font:
    minor-bidi;mso-bidi-theme-font:minor-bidi'><o:p></o:p></span></b></p>
    <p class=MsoListParagraph dir=RTL style='margin-top:0in;margin-right:.5in;
    margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;line-height:normal;mso-pagination:widow-orphan;
    mso-list:l0 level1 lfo1;mso-layout-grid-align:none;direction:rtl;
    unicode-bidi:embed'><![if !supportLists]><span lang=EN-GB style='font-size:
    12.0pt;font-family:"Arial",sans-serif;mso-fareast-font-family:Arial;
    mso-fareast-language:EN-US'><span style='mso-list:Ignore'>-<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US;mso-bidi-language:AR-SA'>الدواء</span><span lang=AR-SA
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>مستحضر</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>يؤثر</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>على</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>صحتك،</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>واستهلاكه</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>خلافا</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>للتعليمات</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>يعرضك</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>للخطر</span><span
    dir=LTR></span><span lang=EN-GB dir=LTR style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'><span dir=LTR></span>.<o:p></o:p></span></p>
    <p class=MsoListParagraph dir=RTL style='margin-top:0in;margin-right:.5in;
    margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;line-height:normal;mso-pagination:widow-orphan;
    mso-list:l0 level1 lfo1;mso-layout-grid-align:none;direction:rtl;
    unicode-bidi:embed'><![if !supportLists]><span lang=EN-GB style='font-size:
    12.0pt;font-family:"Arial",sans-serif;mso-fareast-font-family:Arial;
    mso-fareast-language:EN-US'><span style='mso-list:Ignore'>-<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US;mso-bidi-language:AR-SA'>اتبع</span><span lang=AR-SA
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>بدقة</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>وصفة</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>الطبيب،</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>وطريقة</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>الاستعمال</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>المنصوص</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>عليها،</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>وتعليمات</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>الصيدلانى</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>الذى</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>صرفها</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>لك</span><span dir=LTR></span><span lang=EN-GB dir=LTR
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US'><span dir=LTR></span>.<o:p></o:p></span></p>
    <p class=MsoListParagraph dir=RTL style='margin-top:0in;margin-right:.5in;
    margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;line-height:normal;mso-pagination:widow-orphan;
    mso-list:l0 level1 lfo1;mso-layout-grid-align:none;direction:rtl;
    unicode-bidi:embed'><![if !supportLists]><span lang=EN-GB style='font-size:
    12.0pt;font-family:"Arial",sans-serif;mso-fareast-font-family:Arial;
    mso-fareast-language:EN-US'><span style='mso-list:Ignore'>-<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US;mso-bidi-language:AR-SA'>فالطبيب</span><span lang=AR-SA
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>والصيدلانى</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>هما</span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>الخبيران</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>بالدواء،</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>وبنفعه</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>وضرره</span><span
    dir=LTR></span><span lang=EN-GB dir=LTR style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'><span dir=LTR></span>.<o:p></o:p></span></p>
    <p class=MsoListParagraph dir=RTL style='margin-top:0in;margin-right:.5in;
    margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;line-height:normal;mso-pagination:widow-orphan;
    mso-list:l0 level1 lfo1;mso-layout-grid-align:none;direction:rtl;
    unicode-bidi:embed'><![if !supportLists]><span lang=EN-GB style='font-size:
    12.0pt;font-family:"Arial",sans-serif;mso-fareast-font-family:Arial;
    mso-fareast-language:EN-US'><span style='mso-list:Ignore'>-<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US;mso-bidi-language:AR-SA'>لا</span><span lang=AR-SA style='font-size:
    12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;
    mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>تقطع</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>مدة</span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>العلاج</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>المحددة</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>لك</span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>من</span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>تلقاء</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>نفسك</span><span
    dir=LTR></span><span lang=EN-GB dir=LTR style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'><span dir=LTR></span>.<o:p></o:p></span></p>
    <p class=MsoListParagraph dir=RTL style='margin-top:0in;margin-right:.5in;
    margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;line-height:normal;mso-pagination:widow-orphan;
    mso-list:l0 level1 lfo1;mso-layout-grid-align:none;direction:rtl;
    unicode-bidi:embed'><![if !supportLists]><span lang=EN-GB style='font-size:
    12.0pt;font-family:"Arial",sans-serif;mso-fareast-font-family:Arial;
    mso-fareast-language:EN-US'><span style='mso-list:Ignore'>-<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US;mso-bidi-language:AR-SA'>لا</span><span lang=AR-SA style='font-size:
    12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;
    mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>تكرر</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>صرف</span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>الدواء</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>بدون</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>استشارة</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>الطبيب</span><span
    dir=LTR></span><span lang=EN-GB dir=LTR style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'><span dir=LTR></span>.<o:p></o:p></span></p>
    <p class=MsoListParagraph dir=RTL style='margin-top:0in;margin-right:.5in;
    margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;mso-add-space:auto;
    text-align:right;text-indent:-.25in;line-height:normal;mso-pagination:widow-orphan;
    mso-list:l0 level1 lfo1;mso-layout-grid-align:none;direction:rtl;
    unicode-bidi:embed'><![if !supportLists]><span lang=EN-GB style='font-size:
    12.0pt;font-family:"Arial",sans-serif;mso-fareast-font-family:Arial;
    mso-fareast-language:EN-US'><span style='mso-list:Ignore'>-<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US;mso-bidi-language:AR-SA'>احتفظ</span><span lang=AR-SA
    style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-ascii-theme-font:
    minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;mso-fareast-language:
    EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>بجميع</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>الأدوية</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>بعيداً</span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>عن</span><span lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US'> </span><span lang=AR-SA style='font-size:12.0pt;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;mso-bidi-language:
    AR-SA'>متناول</span><span lang=AR-SA style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'> </span><span
    lang=AR-SA style='font-size:12.0pt;font-family:"Arial",sans-serif;
    mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
    minor-latin;mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>لأطفال</span><span
    dir=LTR></span><span lang=EN-GB dir=LTR style='font-size:12.0pt;font-family:
    "Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-fareast-font-family:
    Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-bidi;
    mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US'><span dir=LTR></span>.<o:p></o:p></span></p>
    <p class=MsoNormal align=center dir=RTL style='margin-right:3.5in;
    text-align:center'><span lang=AR-SA style='font-size:12.0pt;line-height:
    107%;font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi'>مجلس وزراء
    الصحة العرب</span><span dir=LTR style='font-size:12.0pt;line-height:107%;
    font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;mso-hansi-theme-font:
    minor-bidi;mso-bidi-theme-font:minor-bidi'><o:p></o:p></span></p>
    <p class=MsoNormal align=center dir=RTL style='margin-right:3.5in;
    text-align:center'><span lang=AR-SA style='font-size:12.0pt;line-height:
    107%;font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi'>اتحاد
    الصيادلة العرب</span><span dir=LTR style='font-size:12.0pt;line-height:
    107%;font-family:"Arial",sans-serif;mso-ascii-theme-font:minor-bidi;
    mso-hansi-theme-font:minor-bidi;mso-bidi-theme-font:minor-bidi'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap anchorx="page"/>
</v:roundrect><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">علامة تجارية مملوكة أو مرخصة لمجموعة شركات .<strong>GSK</strong></p><p dir="RTL"><strong>ﺣﻘوق اﻟطﺑﻊ &copy; ﻟﻌﺎم </strong><strong>2024</strong><strong> ﻣﺣﻔوظﺔ ﻟ </strong><strong>GlaxoSmithKline</strong><strong>. ﺟﻣﯾﻊ اﻟﺣﻘوق ﻣﺣﻔوظﺔ</strong><strong>.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ﻣﺎﻟﻚ اﻟﺘﺴﻮﯾﻖ اﻟﻤﻌﺘﻤﺪ:</strong></p><p dir="RTL">.Glaxo Saudi Arabia Ltd* ﺟﺪة، اﻟﻤﻤﻠﻜﺔ اﻟﻌﺮﺑﯿﺔ اﻟﺴﻌﻮدﯾﺔ</p><p dir="RTL">اﻟﻌﻨﻮان: ص. ب. 22617 ﺟﺪة 21416 &ndash; اﻟﻤﻤﻠﻜﺔ اﻟﻌﺮﺑﯿﺔ اﻟﺴﻌﻮدﯾﺔ.</p><p dir="RTL">إحدى شركات GlaxoSmithKline.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﺸﺮﻛﺔ اﻟﻤُﺼﻨﻌﺔ:&nbsp; </strong></p><p dir="RTL">GSK Vaccines S.r.l GlaxoSmithKline Biologicals s.a.</p><p dir="RTL">Rue de l&rsquo;Institut 89</p><p dir="RTL">B-1330 Rixensart</p><p dir="RTL">Belgium</p><p dir="RTL">&nbsp;</p><p dir="RTL">. <strong>للإستفسار عن أي معلومات عن هذا المستحضر الدوائي، يرجى الإتصال بالأرقام التالية:</strong></p><p dir="RTL"><strong>&nbsp;جلاكسو سميث كلاين &ndash; المكتب اﻟﺮﺋﯿﺴﻲ، ﺟﺪة</strong></p><ul><li dir="RTL">هاتف: +966-(12)-6536666</li><li dir="RTL">جوّال:&nbsp; +966-56-904-9882</li><li dir="RTL">البريد اًللكتروني: gcc.medinfo@gsk.com</li><li dir="RTL">الموقع اًلإلكتروني: https://gskpro.com/en-sa/</li><li dir="RTL">ص.ب رقم 55850 ، جدة 21544 ، المملكة العربية السعودية</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            رﻗم اﻹﺻدار: UK issue11draft  
ﺗﺎرﯾﺦ اﻹﺻدار: 03 March 2022


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rotarix oral suspension in pre-filled oral applicator
Rotavirus vaccine, live

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 dose (1.5 mL) contains:

Human rotavirus RIX4414 strain (live, attenuated)*	not less than 106.0 CCID50

*Produced on Vero cells

Excipient with known effect:
This product contains sucrose 1,073 mg (see section 4.4).

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral suspension.
Rotarix is a clear and colourless liquid.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rotarix is indicated for the active immunisation of infants aged 6 to 24 weeks for prevention of gastro-enteritis due to rotavirus infection (see sections 4.2, 4.4 and 5.1).</p><p>The use of Rotarix should be based on official recommendations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p><u>Posology</u></p><p>&nbsp;</p><p>The vaccination course consists of two doses. The first dose may be administered from the age of 6 weeks. There should be an interval of at least 4 weeks between doses. The vaccination course should preferably be given before 16 weeks of age, but must be completed by the age of 24 weeks.</p><p>&nbsp;</p><p>Rotarix may be given with the same posology to preterm infants born after at least 27 weeks of gestational age (see sections 4.8 and 5.1).</p><p>&nbsp;</p><p>In clinical trials, spitting or regurgitation of the vaccine has rarely been observed and, under such circumstances, a replacement dose was not given. However, in the unlikely event that an infant spits out or regurgitates most of the vaccine dose, a single replacement dose may be given at the same vaccination visit.</p><p>&nbsp;</p><p>It is recommended that infants who receive a first dose of Rotarix complete the 2-dose regimen with Rotarix. There are no data on safety, immunogenicity or efficacy when Rotarix is administered for the first dose and another rotavirus vaccine is administered for the second dose or vice versa.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>&nbsp;</p><p>Rotarix should not be used in children over 24 weeks of age.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>&nbsp;</p><p>Rotarix is for <strong>oral</strong> use only.</p><p>&nbsp;</p><p><strong>Rotarix should under no circumstances be injected.</strong></p><p>&nbsp;</p><p>For instructions for administration, see section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

Hypersensitivity after previous administration of rotavirus vaccines.

History of intussusception.

Subjects with uncorrected congenital malformation of the gastrointestinal tract that would predispose for intussusception.

Subjects with Severe Combined Immunodeficiency (SCID) disorder (see section 4.8).

Administration of Rotarix should be postponed in subjects suffering from acute severe febrile illness. The presence of a minor infection is not a contra-indication for immunisation.

The administration of Rotarix should be postponed in subjects suffering from diarrhoea or vomiting.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>It is good clinical practice that vaccination should be preceded by a review of the medical history especially with regard to the contraindications and by a clinical examination.</p><p>&nbsp;</p><p>There are no data on the safety and efficacy of Rotarix in infants with gastrointestinal illnesses or growth retardation. Administration of Rotarix may be considered with caution in such infants when, in the opinion of the physician, withholding the vaccine entails a greater risk.</p><p>&nbsp;</p><p>As a precaution, healthcare professionals should follow-up on any symptoms indicative of intussusception (severe abdominal pain, persistent vomiting, bloody stools, abdominal bloating and/or high fever) since data from observational safety studies indicate an increased risk of intussusception, mostly within 7 days after rotavirus vaccination (see section 4.8). Parents/guardians should be advised to promptly report such symptoms to their healthcare provider.</p><p>&nbsp;</p><p>For subjects with a predisposition for intussusception, see section 4.3.</p><p>&nbsp;</p><p>Asymptomatic and mildly symptomatic HIV infections are not expected to affect the safety or efficacy of Rotarix. A clinical study in a limited number of asymptomatic or mildly symptomatic HIV positive infants showed no apparent safety problems (see section 4.8).</p><p>Administration of Rotarix to infants who have known or suspected immunodeficiency, including <em>in utero</em> exposure to an immunosuppressive treatment, should be based on careful consideration of potential benefits and risks.</p><p>&nbsp;</p><p>Excretion of the vaccine virus in the stools is known to occur after vaccination with peak excretion around the 7th day. Viral antigen particles detected by ELISA were found in 50% of stools after the first dose of Rotarix lyophilised formulation and 4% of stools after the second dose. When these stools were tested for the presence of live vaccine strain, only 17% were positive. In two comparative controlled trials, vaccine shedding after vaccination with Rotarix liquid formulation was comparable to that observed after vaccination with Rotarix lyophilised formulation.</p><p>&nbsp;</p><p>Cases of transmission of this excreted vaccine virus to seronegative contacts of vaccinees have been observed without causing any clinical symptom.</p><p>&nbsp;</p><p>Rotarix should be administered with caution to individuals with immunodeficient close contacts, such as individuals with malignancies, or who are otherwise immunocompromised or individuals receiving immunosuppressive therapy.</p><p>&nbsp;</p><p>Contacts of recent vaccinees should observe personal hygiene (e.g. wash their hands after changing child&rsquo;s nappies).</p><p>&nbsp;</p><p>The potential risk of apnoea and the need for respiratory monitoring for 48-72h should be considered when administering the primary immunisation series to very premature infants (born &le; 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity.</p><p>&nbsp;</p><p>As the benefit of the vaccination is high in this group of infants, vaccination should not be withheld or delayed.</p><p>&nbsp;</p><p>A protective immune response may not be elicited in all vaccinees (see section 5.1).</p><p>&nbsp;</p><p>The extent of protection that Rotarix might provide against other rotavirus strains&nbsp; that have not been circulating in clinical trials is currently unknown.&nbsp; Clinical studies from which efficacy data were derived were conducted in Europe, Central and South America, Africa and Asia (see section 5.1).</p><p>&nbsp;</p><p>Rotarix does not protect against gastro-enteritis due to other pathogens than rotavirus.</p><p>&nbsp;</p><p>No data are available on the use of Rotarix for post-exposure prophylaxis.</p><p>&nbsp;</p><p><strong>Rotarix should under no circumstances be injected.</strong></p><p>&nbsp;</p><p><u>&nbsp;</u></p><p><u>Excipients</u></p><p>&nbsp;</p><p>This vaccine contains sucrose and glucose as excipients. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this vaccine.</p><p>&nbsp;</p><p>This vaccine contains 0.15&nbsp;microgram phenylalanine in each dose. Phenylalanine may be harmful for patients with phenylketonuria (PKU).</p><p>&nbsp;</p><p>This vaccine contains 32&nbsp;mg sodium in each dose.</p><p>&nbsp;</p><p><u>Traceability</u></p><p>&nbsp;</p><p>In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rotarix can be given concomitantly with any of the following monovalent or combination vaccines [including hexavalent vaccines (DTPa-HBV-IPV/Hib)]: diphtheria-tetanus-whole cell pertussis vaccine (DTPw), diphtheria-tetanus-acellular pertussis vaccine (DTPa), <em>Haemophilus influenzae</em> type b vaccine (Hib), inactivated polio vaccine (IPV), hepatitis B vaccine (HBV), pneumococcal conjugate vaccine and meningococcal serogroup C conjugate vaccine. Clinical studies demonstrated that the immune responses and the safety profiles of the administered vaccines were unaffected.</p><p>&nbsp;</p><p>Concomitant administration of Rotarix and oral polio vaccine (OPV) does not affect the immune response to the polio antigens. Although concomitant administration of OPV may slightly reduce the immune response to rotavirus vaccine, clinical protection against severe rotavirus gastro-enteritis was shown to be maintained in a clinical trial involving more than 4 200 subjects who received Rotarix concomitantly with OPV.</p><p>&nbsp;</p><p>Immunosuppressive therapies including irradiation, antimetabolites, alkylating agents, cytotoxic drugs and corticosteroids (used in greater than physiologic doses), may reduce the immune response to vaccines.</p><p>&nbsp;</p><p>There are no restrictions on the infant&rsquo;s consumption of food or liquid, either before or after vaccination.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rotarix is not intended for use in adults. There are no data on the use of Rotarix during pregnancy and lactation.</p><p>&nbsp;</p><p>Based on evidence generated in clinical trials, breast-feeding does not reduce the protection against rotavirus gastro-enteritis afforded by Rotarix. Therefore, breast-feeding may be continued during the vaccination schedule.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Not relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Summary of the safety profile</strong></p><p>&nbsp;</p><p>The safety profile presented below is based on data from clinical trials conducted with either the lyophilised or the liquid formulation of Rotarix.</p><p>In a total of four clinical trials, approximately 3 800 doses of Rotarix liquid formulation were administered to approximately 1 900 infants. Those trials have shown that the safety profile of the liquid formulation is comparable to the lyophilised formulation.</p><p>&nbsp;</p><p>In a total of twenty-three clinical trials, approximately 106 000 doses of Rotarix (lyophilised or liquid formulation)<em> </em>were administered to approximately 51 000 infants.</p><p>&nbsp;</p><p>In three placebo-controlled clinical trials (Finland, India and Bangladesh), in which Rotarix was administered alone (administration of routine paediatric vaccines was staggered), the incidence and severity of the solicited events (collected 8 days post-vaccination), diarrhoea, vomiting, loss of appetite, fever, irritability and cough/runny nose were not significantly different in the group receiving Rotarix when compared to the group receiving placebo. No increase in the incidence or severity of these events was seen with the second dose.</p><p>&nbsp;</p><p>In a pooled analysis from seventeen placebo-controlled clinical trials (Europe, North America, Latin America, Asia, Africa) including trials in which Rotarix was co-administered with routine paediatric vaccines (see section 4.5), the following adverse reactions (collected 31 days post-vaccination) were considered as possibly related to vaccination.</p><p>&nbsp;</p><p><strong>Tabulated list of adverse reactions</strong></p><p>Adverse reactions reported are listed according to the following frequency:</p><p>&nbsp;</p><p>Frequencies are reported as:</p><p>Very common (&sup3;1/10)</p><p>Common&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(&sup3;1/100 to &lt;1/10)</p><p>Uncommon &nbsp;&nbsp;&nbsp;&nbsp;(&sup3;1/1 000 to &lt;1/100)</p><p>Rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(&sup3;1/10 000 to &lt;1/1 000)</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(&lt;1/10 000)</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reactions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Diarrhoea</p></td></tr><tr><td style="vertical-align:top"><p><em>&nbsp;</em></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Abdominal pain, flatulence</p></td></tr><tr><td style="vertical-align:top"><p><em>&nbsp;</em></p></td><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Intussusception (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p><em>&nbsp;</em></p></td><td style="vertical-align:top"><p>Not known*</p></td><td style="vertical-align:top"><p>Haematochezia</p></td></tr><tr><td style="vertical-align:top"><p><em>&nbsp;</em></p></td><td style="vertical-align:top"><p>Not known*</p></td><td style="vertical-align:top"><p>Gastroenteritis with vaccine viral shedding in infants with Severe Combined Immunodeficiency (SCID) disorder</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Dermatitis</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Urticaria</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Irritability</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Not known*</p></td><td style="vertical-align:top"><p>Apnoea in very premature infants (&le; 28 weeks of gestation) (see section 4.4)</p></td></tr></tbody></table><p><strong><em>* </em></strong>Because these events were reported spontaneously, it is not possible to reliably estimate their frequency.</p><p><u>&nbsp;</u></p><p><strong>Description of selected adverse reactions</strong></p><p>&nbsp;</p><p><u>Intussusception</u></p><p><u>&nbsp;</u></p><p>Data from observational safety studies performed in several countries indicate that rotavirus vaccines carry an increased risk of intussusception, mostly within 7 days of vaccination. Up to 6 additional cases per 100,000 infants have been observed in these countries against a background incidence of 25 to 101 per 100,000 infants (less than one year of age) per year, respectively.</p><p>There is limited evidence of a smaller increased risk following the second dose.</p><p>It remains unclear whether rotavirus vaccines affect the overall incidence of intussusception based on longer periods of follow-up (see section 4.4).</p><p>&nbsp;</p><p><strong>Other special populations </strong></p><p><u>&nbsp;</u></p><p><u>Safety in preterm infants</u></p><p><u>&nbsp;</u></p><p>In a clinical study, 670 pre-term infants from 27 to 36 weeks of gestational age were administered Rotarix lyophilised formulation and 339 received placebo. The first dose was administered from 6 weeks after birth. Serious adverse events were observed in 5.1% of recipients of Rotarix as compared with 6.8% of placebo recipients. Similar rates of other adverse events were observed in Rotarix and placebo recipients. No cases of intussusception were reported.</p><p>&nbsp;</p><p><u>Safety in infants with human immunodeficiency (HIV) infection</u></p><p>&nbsp;</p><p>In a clinical study, 100 infants with HIV infection were administered Rotarix lyophilised formulation or placebo. The safety profile was similar between Rotarix and placebo recipients.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com</p><p>&middot;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/&nbsp;&nbsp;</p><p>&middot;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong><!--[if supportFields]><b><span style='font-size:
12.0pt;line-height:115%;font-family:"Times New Roman",serif;mso-fareast-font-family:
"Times New Roman";layout-grid-mode:line'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_7009aae8-eeee-4296-b98d-2b6f5edc7f59 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span></b><![endif]--><strong>&nbsp;</strong><!--[if supportFields]><b><span
style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";layout-grid-mode:line'><span
style='mso-element:field-end'></span></span></b><![endif]--></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>&middot;&nbsp;&nbsp; Reporting Hotline: 19999</p><p>&middot;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><p><strong>-GSK - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Email: <u>s</u>audi.safety@gsk.com<u>&nbsp; </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; website: https://gskpro.com/en-sa/<u> </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Some cases of overdose have been reported. In general, the adverse event profile reported in these cases was similar to that observed after administration of the recommended dose of Rotarix.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmaco-therapeutic group: rotavirus diarrhoea vaccines, ATC code: J07BH01</p><p>&nbsp;</p><p><u>Protective efficacy of the lyophilised formulation</u></p><p>&nbsp;</p><p>In clinical trials, efficacy was demonstrated against gastro-enteritis due to rotavirus of the most common genotypes G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. In addition, efficacy against uncommon rotavirus genotypes G8P[4](severe gastro-enteritis) and G12P[6] (any gastro-enteritis) has been demonstrated. These strains are circulating worldwide.</p><p>&nbsp;</p><p>Clinical studies have been conducted in Europe, Latin America, Africa and Asia to evaluate the protective efficacy of Rotarix against any and severe rotavirus gastro-enteritis (RVGE).</p><p>&nbsp;</p><p>Severity of gastro-enteritis was defined according to two different criteria:</p><p>- the Vesikari 20-point scale, which evaluates the full clinical picture of rotavirus gastro-enteritis by taking into account the severity and duration of diarrhoea and vomiting, the severity of fever and dehydration as well as the need for treatment</p><p>or</p><p>- the clinical case definition based on World Health Organization (WHO) criteria</p><p>&nbsp;</p><p>Clinical protection was assessed in the ATP cohort for efficacy, which includes all subjects from the ATP cohort for safety who entered into the concerned efficacy follow-up period.</p><p><u>&nbsp;</u></p><p><u>Protective efficacy in Europe</u></p><p>&nbsp;</p><p>A clinical study performed in Europe evaluated Rotarix given according to different European schedules (2, 3 months; 2, 4 months; 3, 4 months; 3, 5 months) in 4,000 subjects.</p><p>&nbsp;</p><p>After two doses of Rotarix, the protective vaccine efficacy observed during the first and second year of life is presented in the following table:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:527px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p><strong>1<sup>st</sup> year of life</strong></p><p>Rotarix N=2,572</p><p>Placebo N=1,302</p></td><td colspan="2" style="vertical-align:top"><p><strong>2<sup>nd</sup> year of life</strong></p><p>Rotarix N=2,554</p><p>Placebo N=1,294</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Vaccine efficacy (%) against any and severe rotavirus gastro-enteritis</strong></p><p><strong>[95% CI]</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Genotype</strong></p></td><td style="vertical-align:top"><p><strong>Any severity</strong></p></td><td style="vertical-align:top"><p><strong>Severe</strong><sup>&dagger;</sup></p></td><td style="vertical-align:top"><p><strong>Any severity</strong></p></td><td style="vertical-align:top"><p><strong>Severe</strong><sup>&dagger;</sup></p></td></tr><tr><td style="vertical-align:top"><p>G1P[8]</p></td><td style="vertical-align:top"><p>95.6</p><p>[87.9;98.8]</p></td><td style="vertical-align:top"><p>96.4</p><p>[85.7;99.6]</p></td><td style="vertical-align:top"><p>82.7</p><p>[67.8;91.3]</p></td><td style="vertical-align:top"><p>96.5</p><p>[86.2;99.6]</p></td></tr><tr><td style="vertical-align:top"><p>G2P[4]</p></td><td style="vertical-align:top"><p>62.0*</p><p>[&lt;0.0;94.4]</p></td><td style="vertical-align:top"><p>74.7*</p><p>[&lt;0.0;99.6]</p></td><td style="vertical-align:top"><p>57.1</p><p>[&lt;0.0;82.6]</p></td><td style="vertical-align:top"><p>89.9</p><p>[9.4;99.8]</p></td></tr><tr><td style="vertical-align:top"><p>G3P[8]</p></td><td style="vertical-align:top"><p>89.9</p><p>[9.5;99.8]</p></td><td style="vertical-align:top"><p>100</p><p>[44.8;100]</p></td><td style="vertical-align:top"><p>79.7</p><p>[&lt;0.0;98.1]</p></td><td style="vertical-align:top"><p>83.1*</p><p>[&lt;0.0;99.7]</p></td></tr><tr><td style="vertical-align:top"><p>G4P[8]</p></td><td style="vertical-align:top"><p>88.3</p><p>[57.5;97.9]</p></td><td style="vertical-align:top"><p>100</p><p>[64.9;100]</p></td><td style="vertical-align:top"><p>69.6*</p><p>[&lt;0.0;95.3]</p></td><td style="vertical-align:top"><p>87.3</p><p>[&lt;0.0;99.7]</p></td></tr><tr><td style="vertical-align:top"><p>G9P[8]</p></td><td style="vertical-align:top"><p>75.6</p><p>[51.1;88.5]</p></td><td style="vertical-align:top"><p>94.7</p><p>[77.9;99.4]</p></td><td style="vertical-align:top"><p>70.5</p><p>[50.7;82.8]</p></td><td style="vertical-align:top"><p>76.8</p><p>[50.8;89.7]</p></td></tr><tr><td style="vertical-align:top"><p>Strains with P[8] genotype</p></td><td style="vertical-align:top"><p>88.2</p><p>[80.8;93.0]</p></td><td style="vertical-align:top"><p>96.5</p><p>[90.6;99.1]</p></td><td style="vertical-align:top"><p>75.7</p><p>[65.0;83.4]</p></td><td style="vertical-align:top"><p>87.5</p><p>[77.8;93.4]</p></td></tr><tr><td style="vertical-align:top"><p>Circulating rotavirus strains</p></td><td style="vertical-align:top"><p>87.1</p><p>[79.6;92.1]</p></td><td style="vertical-align:top"><p>95.8</p><p>[89.6;98.7]</p></td><td style="vertical-align:top"><p>71.9</p><p>[61.2;79.8]</p></td><td style="vertical-align:top"><p>85.6</p><p>[75.8;91.9]</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Vaccine efficacy (%) against rotavirus gastro-enteritis requiring medical attention</strong></p><p><strong>[95% CI]</strong></p></td></tr><tr><td style="vertical-align:top"><p>Circulating rotavirus strains</p></td><td colspan="2" style="vertical-align:top"><p>91.8</p><p>[84;96.3]</p></td><td colspan="2" style="vertical-align:top"><p>76.2</p><p>[63.0;85.0]</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Vaccine efficacy (%) against hospitalisation due to rotavirus gastro-enteritis</strong></p><p><strong>[95% CI]</strong></p></td></tr><tr><td style="vertical-align:top"><p>Circulating rotavirus strains</p></td><td colspan="2" style="vertical-align:top"><p>100</p><p>[81.8;100]</p></td><td colspan="2" style="vertical-align:top"><p>92.2</p><p>[65.6;99.1]</p></td></tr></tbody></table><p><sup>&dagger;</sup> Severe gastro-enteritis was defined as a score &sup3;11 on the Vesikari scale</p><p>* Not statistically significant (p &sup3; 0.05). These data should be interpreted with caution</p><p>&nbsp;</p><p>Vaccine efficacy during the first year of life progressively increased with increasing disease severity, reaching 100% (95% CI: 84.7;100) for Vesikari scores &sup3;17.</p><p>&nbsp;</p><p><u>Protective efficacy in Latin America</u></p><p>&nbsp;</p><p>A clinical study performed in Latin America evaluated Rotarix in more than 20 000 subjects. Severity of gastro-enteritis (GE) was defined according to WHO criteria. The protective vaccine efficacy against severe rotavirus (RV) gastro-enteritis requiring hospitalisation and/or rehydration therapy in a medical facility and the genotype specific vaccine efficacy after two doses of Rotarix are presented in the table below:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Genotype</strong></p></td><td style="vertical-align:top"><p><strong>Severe rotavirus gastro-enteritis&dagger; (1<sup>st</sup> year of life)</strong></p><p><strong>Rotarix N=9,009 </strong></p><p><strong>Placebo N=8,858 </strong></p></td><td style="vertical-align:top"><p><strong>Severe rotavirus gastro-enteritis&dagger; (2<sup>nd</sup> year of life)</strong><strong><sup> </sup></strong><strong>Rotarix N=7,175</strong></p><p><strong>Placebo N=7,062</strong><strong> </strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>Efficacy (%)</strong></p><p><strong>[</strong><strong>95% CI </strong><strong>]</strong></p></td><td style="vertical-align:top"><p><strong>Efficacy (%)</strong></p><p><strong>[</strong><strong>95% CI </strong><strong>]</strong></p></td></tr><tr><td style="vertical-align:top"><p>All RVGE</p></td><td style="vertical-align:top"><p>84.7</p><p>[71.7;92.4]</p></td><td style="vertical-align:top"><p>79.0</p><p>[66.4;87.4]</p></td></tr><tr><td style="vertical-align:top"><p>G1P[8]</p></td><td style="vertical-align:top"><p>91.8</p><p>[74.1;98.4]</p></td><td style="vertical-align:top"><p>72.4</p><p>[34.5;89.9]</p></td></tr><tr><td style="vertical-align:top"><p>G3P[8]</p></td><td style="vertical-align:top"><p>87.7</p><p>[8.3;99.7]</p></td><td style="vertical-align:top"><p>71.9*</p><p>[&lt;0.0;97.1]</p></td></tr><tr><td style="vertical-align:top"><p>G4P[8]</p></td><td style="vertical-align:top"><p>50.8#*</p><p>[&lt;0.0;99.2]</p></td><td style="vertical-align:top"><p>63.1</p><p>[0.7;88.2]</p></td></tr><tr><td style="vertical-align:top"><p>G9P[8]</p></td><td style="vertical-align:top"><p>90.6</p><p>[61.7;98.9]</p></td><td style="vertical-align:top"><p>87.7</p><p>[72.9;95.3]</p></td></tr><tr><td style="vertical-align:top"><p>Strains with P[8] genotype</p></td><td style="vertical-align:top"><p>90.9</p><p>[79.2;96.8]</p></td><td style="vertical-align:top"><p>79.5</p><p>[67.0;87.9]</p></td></tr></tbody></table><p>&dagger; Severe rotavirus gastro-enteritis was defined as an episode of diarrhoea with or without vomiting that required hospitalisation and/or re-hydration therapy in a medical facility (WHO criteria)</p><p>* Not statistically significant (p &sup3; 0.05). These data should be interpreted with caution</p><p># The numbers of cases, on which the estimates of efficacy against G4P[8] were based, were very small (1 case in the Rotarix group and 2 cases in the placebo group)</p><p>&nbsp;</p><p>A pooled analysis of five efficacy studies*, showed a 71.4% (95% CI: 20.1;91.1) efficacy against severe rotavirus gastro-enteritis (Vesikari score &sup3;11) caused by rotavirus G2P[4] genotype during the first year of life.</p><p>* In these studies, the point estimates and confidence intervals were respectively: 100% (95% CI: -1 858.0;100), 100% (95% CI: 21.1;100), 45.4% (95% CI: -81.5;86.6), 74.7% (95% CI&nbsp;:-386.2;99.6). No point estimate was available for the remaining study.</p><p>&nbsp;</p><p><u>Protective efficacy in Africa</u></p><p>&nbsp;</p><p>A clinical study performed in Africa (Rotarix: N = 2,974; placebo: N = 1,443) evaluated Rotarix given at approximately 10 and 14 weeks of age (2 doses) or 6, 10 and 14 weeks of age (3 doses). The vaccine efficacy against severe rotavirus gastro-enteritis during the first year of life was 61.2% (95% CI: 44.0;73.2). The protective vaccine efficacy (pooled doses) observed against any and severe rotavirus gastro-enteritis is presented in the following table:</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Genotype</strong></p></td><td style="vertical-align:top"><p><strong>Any rotavirus gastro-enteritis</strong></p><p><strong>Rotarix N=2,974</strong></p><p><strong>Placebo N=1,443</strong></p></td><td style="vertical-align:top"><p><strong>Severe rotavirus gastro-enteritis&dagger;</strong></p><p><strong>Rotarix N=2,974</strong></p><p><strong>Placebo N=1,443</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>Efficacy (%)</strong></p><p><strong>[</strong><strong>95% CI</strong><strong>]</strong></p></td><td style="vertical-align:top"><p><strong>Efficacy (%)</strong></p><p><strong>[</strong><strong>95% CI</strong><strong>]</strong></p></td></tr><tr><td style="vertical-align:top"><p>G1P[8]</p></td><td style="vertical-align:top"><p>68.3</p><p>[53.6;78.5]</p></td><td style="vertical-align:top"><p>56.6</p><p>[11.8;78.8]</p></td></tr><tr><td style="vertical-align:top"><p>G2P[4]</p></td><td style="vertical-align:top"><p>49.3</p><p>[4.6;73.0]</p></td><td style="vertical-align:top"><p>83.8</p><p>[9.6;98.4]</p></td></tr><tr><td style="vertical-align:top"><p>G3P[8]</p></td><td style="vertical-align:top"><p>43.4*</p><p>[&lt;0.0;83.7]</p></td><td style="vertical-align:top"><p>51.5*</p><p>[&lt;0.0;96.5]</p></td></tr><tr><td style="vertical-align:top"><p>G8P[4]</p></td><td style="vertical-align:top"><p>38.7*</p><p>[&lt;0.0;67.8]</p></td><td style="vertical-align:top"><p>63.6</p><p>[5.9;86.5]</p></td></tr><tr><td style="vertical-align:top"><p>G9P[8]</p></td><td style="vertical-align:top"><p>41.8*</p><p>[&lt;0.0;72.3]</p></td><td style="vertical-align:top"><p>56.9*</p><p>[&lt;0.0;85.5]</p></td></tr><tr><td style="vertical-align:top"><p>G12P[6]</p></td><td style="vertical-align:top"><p>48.0</p><p>[9.7;70.0]</p></td><td style="vertical-align:top"><p>55.5*</p><p>[&lt;0.0; 82.2]</p></td></tr><tr><td style="vertical-align:top"><p>Strains with P[4] genotype</p></td><td style="vertical-align:top"><p>39.3</p><p>[7.7;59.9]</p></td><td style="vertical-align:top"><p>70.9</p><p>[37.5;87.0]</p></td></tr><tr><td style="vertical-align:top"><p>Strains with P[6] genotype</p></td><td style="vertical-align:top"><p>46.6</p><p>[9.4;68.4]</p></td><td style="vertical-align:top"><p>55.2*</p><p>[&lt;0.0;81.3]</p></td></tr><tr><td style="vertical-align:top"><p>Strains with P[8] genotype</p></td><td style="vertical-align:top"><p>61.0</p><p>[47.3;71.2]</p></td><td style="vertical-align:top"><p>59.1</p><p>[32.8;75.3]</p></td></tr></tbody></table><p>&dagger; Severe gastro-enteritis was defined as a score <strong><em>&sup3;</em></strong>11 on the Vesikari scale</p><p>* Not statistically significant (p &sup3; 0.05). These data should be interpreted with caution.</p><p><em><u>&nbsp;</u></em></p><p><u>Sustained efficacy up to 3 years of age in Asia</u></p><p>&nbsp;</p><p>A clinical study conducted in Asia (Hong Kong, Singapore and Taiwan) (Total vaccinated cohort: Rotarix: N = 5,359; placebo: N = 5,349) evaluated Rotarix given according to different schedules (2, 4 months of age; 3, 4 months of age).</p><p>&nbsp;</p><p>During the first year, significantly fewer subjects in the Rotarix group reported severe rotavirus gastro-enteritis caused by the circulating wild-type RV compared to the placebo group from 2 weeks after Dose 2 up to one year of age (0.0% versus 0.3%), with a vaccine efficacy of 100% (95% CI: 72.2; 100).</p><p>&nbsp;</p><p>The protective vaccine efficacy after two doses of Rotarix observed against severe rotavirus gastro-enteritis up to 2 years of age is presented in the following table:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:80%"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Efficacy up to 2 years of age</p><p>Rotarix N= 5,263</p><p>Placebo N= 5,256</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Vaccine efficacy (%) against severe rotavirus gastro-enteritis [95% CI]</p></td></tr><tr><td style="vertical-align:top"><p>Genotype</p></td><td style="vertical-align:top"><p>Severe&dagger;</p></td></tr><tr><td style="vertical-align:top"><p>G1P[8]</p></td><td style="vertical-align:top"><p>100 [80.8;100]</p></td></tr><tr><td style="vertical-align:top"><p>G2P[4]</p></td><td style="vertical-align:top"><p>100* [&lt;0.0;100]</p></td></tr><tr><td style="vertical-align:top"><p>G3P[8]</p></td><td style="vertical-align:top"><p>94.5 [64.9;99.9]</p></td></tr><tr><td style="vertical-align:top"><p>G9P[8]</p></td><td style="vertical-align:top"><p>91.7 [43.8;99.8]</p></td></tr><tr><td style="vertical-align:top"><p>Strains with P[8] genotype</p></td><td style="vertical-align:top"><p>95.8 [83.8;99.5]</p></td></tr><tr><td style="vertical-align:top"><p>Circulating rotavirus strains</p></td><td style="vertical-align:top"><p>96.1 [85.1;99.5]</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Vaccine efficacy (%) against rotavirus gastro-enteritis requiring hospitalisation and/or rehydration therapy in a medical facility [95% CI]</p></td></tr><tr><td style="vertical-align:top"><p>Circulating rotavirus strains</p></td><td style="vertical-align:top"><p>94.2 [82.2;98.8]</p></td></tr></tbody></table><p>&dagger; Severe gastro-enteritis was defined as a score &sup3;11 on the Vesikari scale</p><p>* Not statistically significant (p &sup3; 0.05). These data should be interpreted with caution.</p><p><u>&nbsp;</u></p><p>During the third year of life, there were no cases of severe RV gastro-enteritis in the Rotarix group (N=4,222) versus 13 (0.3%) in the placebo group (N=4,185). Vaccine efficacy was 100% (95% CI: 67.5; 100). The severe RV gastro-enteritis cases were due to RV strains G1P[8], G2P[4], G3P[8] and G9P[8]. The incidence of severe RV gastro-enteritis associated with the individual genotypes was too small to allow calculation of efficacy. The efficacy against severe RV gastro-enteritis requiring hospitalisation was 100% (95% CI: 72.4; 100).</p><p><em><u>&nbsp;</u></em></p><p><u>Protective efficacy of the liquid formulation</u></p><p>&nbsp;</p><p>Since the immune response observed after 2 doses of Rotarix liquid formulation was comparable to the immune response observed after 2 doses of Rotarix lyophilised formulation, the levels of vaccine efficacy observed with the lyophilised formulation can be extrapolated to the liquid formulation.</p><p><em><u>&nbsp;</u></em></p><p><u>Immune response</u></p><p>&nbsp;</p><p>The immunologic mechanism by which Rotarix protects against rotavirus gastro-enteritis is not completely understood. A relationship between antibody responses to rotavirus vaccination and protection against rotavirus gastro-enteritis has not been established.</p><p>&nbsp;</p><p>The following table shows the percentage of subjects initially seronegative for rotavirus (IgA antibody titres &lt; 20 U/ml) (by ELISA) with serum anti-rotavirus IgA antibody titres &sup3;20U/ml one to two months after the second dose of vaccine or placebo as observed in different studies with Rotarix lyophilised formulation.</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:510px"><tbody><tr><td style="vertical-align:top"><p><strong>Schedule</strong></p></td><td style="vertical-align:top"><p><strong>Studies conducted in</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Vaccine</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Placebo</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>N</strong></p></td><td style="vertical-align:top"><p><strong>% </strong><strong>&sup3;</strong><strong> &nbsp;20 U/ml</strong></p><p><strong>[</strong><strong>95% CI</strong><strong>]</strong></p></td><td style="vertical-align:top"><p><strong>N</strong></p></td><td style="vertical-align:top"><p><strong>% </strong><strong>&sup3;</strong><strong> &nbsp;20 U/ml</strong></p><p><strong>[</strong><strong>95% CI</strong><strong>]</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>2, 3 months</strong></p></td><td style="vertical-align:top"><p>France, Germany</p></td><td style="vertical-align:top"><p>239</p></td><td style="vertical-align:top"><p>82.8</p><p>[77.5;87.4]</p></td><td style="vertical-align:top"><p>127</p></td><td style="vertical-align:top"><p>8.7</p><p>[4.4;15.0]</p></td></tr><tr><td style="vertical-align:top"><p><strong>2, 4 months</strong></p></td><td style="vertical-align:top"><p>Spain</p></td><td style="vertical-align:top"><p>186</p></td><td style="vertical-align:top"><p>85.5</p><p>[79.6;90.2]</p></td><td style="vertical-align:top"><p>89</p></td><td style="vertical-align:top"><p>12.4</p><p>[6.3;21.0]</p></td></tr><tr><td style="vertical-align:top"><p><strong>3, 5 months</strong></p></td><td style="vertical-align:top"><p>Finland, Italy</p></td><td style="vertical-align:top"><p>180</p></td><td style="vertical-align:top"><p>94.4</p><p>[90.0;97.3]</p></td><td style="vertical-align:top"><p>114</p></td><td style="vertical-align:top"><p>3.5</p><p>[1.0;8.7]</p></td></tr><tr><td style="vertical-align:top"><p><strong>3, 4 months</strong></p></td><td style="vertical-align:top"><p>Czech Republic</p></td><td style="vertical-align:top"><p>182</p></td><td style="vertical-align:top"><p>84.6</p><p>[78.5;89.5]</p></td><td style="vertical-align:top"><p>90</p></td><td style="vertical-align:top"><p>2.2</p><p>[0.3;7.8]</p></td></tr><tr><td style="vertical-align:top"><p><strong>2, 3 to 4 months</strong></p></td><td style="vertical-align:top"><p>Latin America; 11 countries</p></td><td style="vertical-align:top"><p>393</p></td><td style="vertical-align:top"><p>77.9%</p><p>[73.8;81.6]</p></td><td style="vertical-align:top"><p>341</p></td><td style="vertical-align:top"><p>15.1%</p><p>[11.7;19.0]</p></td></tr><tr><td style="vertical-align:top"><p><strong>10, 14 weeks and 6, 10, 14 weeks (Pooled)</strong></p></td><td style="vertical-align:top"><p>South Africa, Malawi</p></td><td style="vertical-align:top"><p>221</p></td><td style="vertical-align:top"><p>58.4</p><p>[51.6;64.9]</p></td><td style="vertical-align:top"><p>111</p></td><td style="vertical-align:top"><p>22.5</p><p>[15.1;31.4]</p></td></tr></tbody></table><p>&nbsp;</p><p>In three comparative controlled trials, the immune response elicited by Rotarix liquid formulation was comparable to the one elicited by Rotarix lyophilised formulation.</p><p>&nbsp;</p><p><u>Immune response in preterm infants</u></p><p><u>&nbsp;</u></p><p>In a clinical study conducted in preterm infants, born after at least 27 weeks of gestational age, the immunogenicity of Rotarix was assessed in a subset of 147 subjects and showed that Rotarix is immunogenic in this population; 85.7% (95% CI: 79.0;90.9) of subjects achieved serum anti-rotavirus IgA antibody titres &sup3; 20U/ml (by ELISA) one month after the second dose of vaccine.</p><p><u>&nbsp;</u></p><p><u>Effectiveness</u></p><p>In observational studies, vaccine effectiveness was demonstrated against severe gastro-enteritis leading to hospitalisation due to rotavirus of common genotypes G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8] as well as the less common rotavirus genotypes G9P[4] and G9P[6]. All of these strains are circulating worldwide.</p><p>&nbsp;</p><p><u>Effectiveness after 2 doses in preventing RVGE leading to hospitalisation</u></p><p>&nbsp;</p><p><u>&nbsp;</u></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Countries</strong></p><p><strong>Period</strong></p></td><td style="vertical-align:top"><p><strong>Age range</strong></p></td><td style="vertical-align:top"><p><strong>N <sup>(1)</sup></strong></p><p><strong>(cases/controls)</strong></p></td><td style="vertical-align:top"><p><strong>Strains</strong></p></td><td style="vertical-align:top"><p><strong>Effectiveness</strong></p><p><strong>% [95% CI]</strong></p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>High Income countries</strong></p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p>Belgium</p><p>2008-2010<sup>(2)</sup></p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&lt; 4 yrs</p><p>3-11 m</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>160/198</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>All</p></td><td style="vertical-align:top"><p>90 [81;95]</p><p>91 [75;97]</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>&lt; 4 yrs</p></td><td style="vertical-align:top"><p>41/53</p></td><td style="vertical-align:top"><p>G1P[8]</p></td><td style="vertical-align:top"><p>95 [78;99]</p></td></tr><tr><td style="vertical-align:top"><p>&lt; 4 yrs</p><p>3-11 m</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>80/103</p></td><td style="vertical-align:top"><p>G2P[4]</p></td><td style="vertical-align:top"><p>85 [64;94]</p><p>83 [22;96] <sup>(3)</sup></p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>&lt; 4 yrs</p></td><td style="vertical-align:top"><p>12/13</p></td><td style="vertical-align:top"><p>G3P[8]</p></td><td style="vertical-align:top"><p>87* [&lt;0;98]<sup>(3)</sup></p></td></tr><tr><td style="vertical-align:top"><p>&lt; 4 yrs</p></td><td style="vertical-align:top"><p>16/17</p></td><td style="vertical-align:top"><p>G4P[8]</p></td><td style="vertical-align:top"><p>90 [19;99] <sup>(3)</sup></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Singapore</p><p>2008-2010<sup>(2)</sup></p></td><td rowspan="2" style="vertical-align:top"><p>&lt; 5 yrs</p></td><td style="vertical-align:top"><p>136/272</p></td><td style="vertical-align:top"><p>All</p></td><td style="vertical-align:top"><p>84 [32;96]</p></td></tr><tr><td style="vertical-align:top"><p>89/89</p></td><td style="vertical-align:top"><p>G1P[8]</p></td><td style="vertical-align:top"><p>91 [30;99]</p></td></tr><tr><td style="vertical-align:top"><p>Taiwan</p><p>2009-2011</p></td><td style="vertical-align:top"><p>&lt; 3 yrs</p></td><td style="vertical-align:top"><p>184/1,623<sup>(4)</sup></p></td><td style="vertical-align:top"><p>All</p><p>G1P[8]</p></td><td style="vertical-align:top"><p>92 [75;98]</p><p>95 [69;100]</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>US</p><p>2010-2011</p></td><td style="vertical-align:top"><p>&lt; 2 yrs</p></td><td rowspan="2" style="vertical-align:top"><p>85/1,062<sup>(5)</sup></p></td><td style="vertical-align:top"><p>All</p><p>G1P[8]</p><p>G2P[4]</p></td><td style="vertical-align:top"><p>85 [73;92]</p><p>88 [68;95]</p><p>88 [68;95]</p></td></tr><tr><td style="vertical-align:top"><p>8-11 m</p></td><td style="vertical-align:top"><p>All</p></td><td style="vertical-align:top"><p>89 [48;98]</p></td></tr><tr><td style="vertical-align:top"><p>US</p><p>2009-2011</p></td><td style="vertical-align:top"><p>&lt; 5 yrs</p></td><td style="vertical-align:top"><p>74/255<sup>(4)</sup></p></td><td style="vertical-align:top"><p>All</p></td><td style="vertical-align:top"><p>68 [34;85]</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Middle Income Countries</strong></p></td></tr><tr><td rowspan="7" style="vertical-align:top"><p>Bolivia</p><p>2010-2011</p></td><td rowspan="2" style="vertical-align:top"><p>&lt; 3 yrs</p><p>6-11 m</p></td><td rowspan="7" style="vertical-align:top"><p>300/974</p></td><td rowspan="2" style="vertical-align:top"><p>All</p></td><td style="vertical-align:top"><p>77 [65;84]<sup>(6)</sup></p></td></tr><tr><td style="vertical-align:top"><p>77 [51;89]</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>&lt; 3 yrs</p><p>6-11 m</p></td><td rowspan="2" style="vertical-align:top"><p>G9P[8]</p></td><td style="vertical-align:top"><p>85 [69;93]</p></td></tr><tr><td style="vertical-align:top"><p>90 [65;97]</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>&lt; 3 yrs</p></td><td style="vertical-align:top"><p>G3P[8]</p></td><td style="vertical-align:top"><p>93 [70;98]</p></td></tr><tr><td style="vertical-align:top"><p>G2P[4]</p></td><td style="vertical-align:top"><p>69 [14;89]</p></td></tr><tr><td style="vertical-align:top"><p>G9P[6]</p></td><td style="vertical-align:top"><p>87 [19;98]</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Brazil</p><p>2008-2011</p></td><td rowspan="3" style="vertical-align:top"><p>&lt; 2 yrs</p></td><td rowspan="3" style="vertical-align:top"><p>115/1,481</p></td><td style="vertical-align:top"><p>All</p></td><td style="vertical-align:top"><p>72 [44;85]<sup>(6)</sup></p></td></tr><tr><td style="vertical-align:top"><p>G1P[8]</p></td><td style="vertical-align:top"><p>89 [78;95]</p></td></tr><tr><td style="vertical-align:top"><p>G2P[4]</p></td><td style="vertical-align:top"><p>76 [64;84]</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Brazil</p><p>2008-2009<sup>(2)</sup></p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&lt; 3 yrs</p><p>3-11 m</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>249/249 <sup>(5)</sup></p></td><td style="vertical-align:top"><p>All</p></td><td style="vertical-align:top"><p>76 [58;86]</p><p>96 [68;99]</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>&lt; 3 yrs</p><p>3-11 m</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>222/222 <sup>(5)</sup></p></td><td style="vertical-align:top"><p>G2P[4]</p></td><td style="vertical-align:top"><p>75 [57;86]</p><p>95 [66;99] <sup>(3)</sup></p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>El Salvador</p><p>2007-2009</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&lt; 2 yrs</p><p>6-11 m</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>251/770 <sup>(5)</sup></p></td><td style="vertical-align:top"><p>All</p></td><td style="vertical-align:top"><p>76 [64;84]<sup>(6)</sup></p><p>83 [68;91]</p></td></tr><tr><td style="vertical-align:top"><p>Guatemala</p><p>2012-2013</p></td><td style="vertical-align:top"><p>&lt; 4 yrs</p></td><td style="vertical-align:top"><p>NA<sup>(7)</sup></p></td><td style="vertical-align:top"><p>All</p></td><td style="vertical-align:top"><p>63 [23;82]</p></td></tr><tr><td style="vertical-align:top"><p>Mexico</p><p>2010</p></td><td style="vertical-align:top"><p>&lt; 2 yrs</p></td><td style="vertical-align:top"><p>9/17<sup>(5)</sup></p></td><td style="vertical-align:top"><p>G9P[4]</p></td><td style="vertical-align:top"><p>94 [16;100]</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Low Income Countries</strong></p></td></tr><tr><td style="vertical-align:top"><p>Malawi</p><p>2012-2014</p></td><td style="vertical-align:top"><p>&lt; 2 yrs</p></td><td style="vertical-align:top"><p>81/286 <sup>(5)</sup></p></td><td style="vertical-align:top"><p>All</p></td><td style="vertical-align:top"><p>63 [23;83]</p></td></tr></tbody></table><p>m: months</p><p>yrs: years</p><p>&nbsp;</p><p>* Not statistically significant (p &sup3; 0.05). These data should be interpreted with caution.</p><p>(1) The number of fully vaccinated (2 doses) and unvaccinated cases and controls is given.</p><p>(2) GSK sponsored studies</p><p>(3) Data from a post-hoc analysis</p><p>&nbsp;</p><p>(4) Vaccine effectiveness was calculated using rotavirus-negative hospital control participants (estimates from Taiwan were calculated using combined&nbsp;rotavirus-negative hospital control&nbsp;and non-diarrhoea hospital control participants).</p><p>(5) Vaccine effectiveness was calculated using neighbourhood controls.</p><p>(6) In subjects who did not receive the full course of vaccination, the effectiveness after one dose ranged from 51% (95% CI: 26;67, El Salvador) to 60% (95% CI: 37; 75, Brazil).</p><p>&nbsp;</p><p>(7) NA: Not available. Vaccine effectiveness estimate is based on 41 fully vaccinated cases and 175 fully vaccinated controls.</p><p><em><u>&nbsp;</u></em></p><p><u>Impact on mortality<sup>&sect;</sup></u></p><p>Impact studies with Rotarix conducted in Panama, Brazil and Mexico showed a decrease in all-cause diarrhoea mortality ranging from 17% to 73% in children less than 5 years of age, within 2 to 4 years after vaccine introduction.</p><p><u>Impact on hospitalisation<sup>&sect;</sup></u></p><p>In a retrospective database study in Belgium conducted in children 5 years of age and younger, the direct and indirect impact of Rotarix vaccination on rotavirus-related hospitalisation ranged from 64% (95% CI: 49;76) to 80% (95% CI: 77;83) two years after vaccine introduction. Similar studies in Armenia, Australia, Brazil, Canada, El Salvador and Zambia showed a reduction of 45 to 93% between 2 and 4 years after vaccine introduction.</p><p>In addition, nine impact studies on all-cause diarrhoea hospitalisation conducted in Africa and Latin America<sup> </sup>showed a reduction of 14% to 57% between 2 and 5 years after vaccine introduction.</p><p><sup>&sect;</sup>NOTE: Impact studies are meant to establish a temporal relationship but not a causal relationship between the disease and vaccination. Natural fluctuations of the incidence of the disease may also influence the observed temporal effect.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of repeated dose toxicity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sucrose</p><p>Di-sodium Adipate</p><p>Dulbecco&rsquo;s Modified Eagle Medium (DMEM)</p><p>Sterile water</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                -	Pre-filled oral applicator: 3 years 

The vaccine should be used immediately after opening.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2&deg;C &ndash; 8&deg;C).</p><p>Do not freeze.</p><p>&nbsp;</p><p>Store in the original package, in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1.5 mL of <strong>oral</strong> suspension in a pre-filled <strong>oral</strong> applicator (type I glass) with a plunger stopper (rubber butyl) and a protective tip cap (rubber butyl) in pack sizes of 1, 5, 10 or 25.</p><p>&nbsp;</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The vaccine is presented as a clear, colourless liquid, free of visible particles, for <strong>oral</strong> administration.</p><p>&nbsp;</p><p>The vaccine is ready to use (no reconstitution or dilution is required).</p><p>The vaccine is to be administered <strong>orally </strong>without mixing with any other vaccines or solutions.</p><p>&nbsp;</p><p>The vaccine should be inspected visually for any foreign particulate matter and/or abnormal physical appearance. In the event of either being observed, discard the vaccine.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p><em><u>&nbsp;</u></em></p><p><u>Instructions for administration of the vaccine in a pre-filled oral applicator</u>:</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shapetype
 id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="Text_x0020_Box_x0020_102" o:spid="_x0000_s1030"
 type="#_x0000_t202" style='position:absolute;margin-left:151.05pt;
 margin-top:142.85pt;width:124.1pt;height:61.6pt;z-index:251660288;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
 mso-height-relative:page;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" stroked="f">
 <v:textbox inset="1mm,.5mm,1mm,0"/>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0"><tbody><tr><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL">.<img src="data:image/png;base64,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" alt="" width="500" height="241" vspace="0" hspace="0" border="0" style="width:500px;height:241px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>Discard the empty <strong>oral </strong>applicator and tip cap in approved biological waste containers according to local regulations.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Rotarix is a trademark owned by or licences to GSK group of companies. </strong></p><p><strong>&copy; 2024 GlaxoSmithKline group of companies. All rights reserved.</strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rotarix is a trademark owned by or licences to GSK group of companies.

© 2024 GlaxoSmithKline group of companies. All rights reserved.

Manufactured by: 

GlaxoSmithKline Biologicals s.a. 
89, rue de l’Institut - 1330 Rixensart 
Belgium Tel: (32) 2 656 81 11 Fax: (32) 2 656 80 00 


Marketing Authorization holder: 

Glaxo Saudi Arabia Ltd.* Jeddah, KSA 
Address: P.O. Box 22617 Jeddah 21416 – Kingdom of Saudi Arabia 
*member of the GlaxoSmithKline group of companies

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
Version number: UK Issue 17 draft1 
Date of issue: 15 March 2024 

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>